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ABSTRACT OF DISSERTATION

EVALUATING THE EFFECTIVENESS OF A CONTINUOUS CLIENT FEEDBACK
SYSTEM FOR PAROLEES REFERRED TO TREATMENT: BENCHMARKING
TREATMENT OUTCOMES
Objective: The purpose of the present study was to evaluate the effectiveness of a group
substance abuse program that incorporated continuous client feedback into treatment for
parolees who had been referred to attend by the criminal justice system.
Method: The pre-post treatment outcomes, as measured by the Outcome Rating Scale
(ORS; Miller & Duncan, 2000), of 1,112 diverse parolees participating in treatment from
October 2014 to January 2015 were analyzed. The most up-to-date benchmarking
methodology was utilized to compare treatment outcomes observed in the naturalistic
setting with those observed in rigorous randomized controlled trials evaluating the
Partners for Change Outcome Management System (Duncan, 2012, 2014; Duncan &
Sparks, 2010). Two sets of benchmarks were constructed for comparison purposes: one
each for the feedback and treatment as usual conditions for two studies of PCOMS in a
group setting and one each for the feedback and treatment as usual conditions for all six
PCOMS studies.
Results: Compared to the feedback condition benchmarks, the average treatment effect
size estimate of psychotherapy for the present sample (d = 0.59) was not found to be
clinically equivalent to the average effect size estimate from the two PCOMS group
studies or to the effect size estimate constructed from all six PCOMS studies. In regards
to treatment as usual, the effect size estimate from the present sample was found to be
clinically superior to treatment as usual from all six PCOMS studies, including the two
group randomized controlled trials.
Conclusions: Despite the documented success in treatment outcomes regarding the use of
continuous client feedback with voluntary clients, results suggest more modest effects
with individuals referred to treatment. Although not found to be equivalent with the
feedback conditions from randomized controlled trials, the use of client feedback with the
present sample resulted in outcomes superior to those of treatment as usual in the six
PCOMS studies. Particular characteristics of offender populations that can impact
psychotherapy, and potentially treatment outcomes, are discussed.
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Chapter One: Introduction and Review of Selected Literature
Due to the high prevalence rates of substance use among offenders, they are often
mandated or referred to attend substance abuse treatment. Group therapy is the most
frequently used format for both voluntary and involuntary substance abuse treatment
(Blume, 1985). However, studies evaluating the effectiveness of group therapy with
offenders (Morgan & Flora, 2002) and substance abuse treatment for offenders (Anglin,
Prendergast, & Farabee, 1998; Howard & McCaughrin, 1996; Klag, O’Callaghan, &
Creed, 2005; Young, 2002) have yielded mixed results.
Two salient characteristics of psychotherapy with offenders coerced to attend
therapy that can potentially undermine treatment are resistance to therapy and lack of
motivation. Client feedback, a process in which the client’s perception of therapy
progress is routinely assessed, has been proposed as a way to improve treatment outcome.
Client feedback allows the therapist to be responsive to clients who are not responding to
treatment and provides a platform for collaboration (Duncan, 2012). Systems for
tracking client progress have been found to improve treatment outcomes for both
individuals (Lambert et al., 2001; Lambert et al., 2002; Miller, Duncan, Brown, Sorrell,
& Chalk, 2006; Reese, Norsworthy, & Rowlands, 2009; Whipple et al., 2003) and
couples (Anker, Duncan, & Sparks, 2009; Reese, Toland, Slone, & Norsworthy, 2010).
Evidence of the effectiveness of client feedback in group settings is emerging, and a
thorough search of the literature failed to find any studies that have evaluated the use of a
client feedback system with offenders referred to attend group treatment. Such a study
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appears warranted given the positive results of research on continuous client feedback
conducted with voluntary clients.
Prevalence of Substance Abuse Among Offenders
Imprisonment, probation, and parole are the most common forms of punishment
and rehabilitation for individuals who are found to directly violate the established laws of
society. The most recent data presented by the Bureau of Justice Statistics (Glaze &
Kaeble, 2014) reported that at the end of 2013, nearly 7 million individuals were under
correctional supervision in the United States. Although this number has declined slightly
since previous years, approximately one out of every 35 adults, or 2.9% of the total
population, is either incarcerated, on probation, or on parole. A closer examination
reveals that 1 in every 51 adults in the United States was supervised in the community on
either parole or probation, and 1 in every 110 adults was incarcerated in either a prison or
jail (Glaze & Kaeble, 2014). Lifetime substance use and substance use in the month prior
to conviction are common characteristics of individuals under correctional supervision.
A national survey of adults on probation (Mumola & Bonczar, 1995) reported
that nearly 70% disclosed some previous drug use in their lifetime, and approximately
32% reported drug use in the month prior to the offense that resulted in probation. A
2002 survey of men and women in local jails found that 68% of inmates were found to be
dependent upon or abusing alcohol and/or drugs, and 55% of convicted inmates reported
having used drugs in the month prior to their offense (Karberg & James, 2005). By 2004,
state prisoner reports of prior drug use were 83%, whereas 79% of federal prisoners
reported prior substance use (Mumola & Karberg, 2006). The 2013 National Survey on
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Drug Use and Health (Substance Abuse and Mental Health Services Administration,
2014) reported 27.4% of adults on parole or other supervised release from prison at some
time during the past year and 31.4% of adults on probation at some time during the past
year were currently using illicit drugs. Due to the prevalence of individuals under the
influence of a substance at the time of the offense and the prevalence of lifetime
substance use among offenders, corrections often incorporates substance abuse treatment
into the inmate, probationer, or parolee’s rehabilitation plan.
Based on the point in the legal process where the individual is pressured to enter
into substance abuse treatment, coercion from the criminal justice system can take several
forms (Klag et al., 2005). Though no longer heavily relied upon, civil commitment is
considered to be the most coercive form for the individual is required to attend treatment
in a secure facility for an extended period of time (Farabee & Leukefeld, 2001). More
commonly, an individual may be coerced into treatment in exchange for a deferred,
reduced, or lifted sentence. Individuals may also be required to complete treatment as a
condition of probation or parole (Rotgers, 1992). Despite the prevalence of substance use
among offenders and the frequent use of coercive treatment, studies examining the
effectiveness of such treatment have generated inconsistent results.
Effectiveness of Substance Abuse Treatment for Offenders
Despite the abundance of research on coerced substance abuse treatment for
offenders, results regarding the effectiveness of such treatment have been mixed (Anglin
et al., 1998; Howard & McCaughrin, 1996; Klag et al., 2005; Young, 2002). Researchers
maintain inconsistencies in study findings can be partly attributed to conceptual and
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methodological problems including a lack of consistent terminology, the failure of early
research to differentiate between the various treatment settings in which coercion can be
applied, the lack of consideration of individual difference factors that can potentially
impact outcomes, failure to consider the interaction of coercion and motivation, and a
failure to differentiate between various levels of coercion (Anglin et al., 1998; Young,
2002).
In regards to inconsistent terminology within the existing literature on work with
involuntary clients, definitions used when describing this particular population can vary
greatly from one article to the next. For example, the terms “criminal justice referred,”
“mandated,” “coerced,” “compulsory,” and “involuntary” are often used interchangeably
and with differing definitions from one article to the next (Anglin et al., 1998).
Unfortunately, no universal criteria are available within the field to explicitly differentiate
this particular group of clients from those who seek services voluntarily.
Regardless of inconsistencies in the findings, coerced treatment for substance
abuse is often a common component of rehabilitation plans for individuals under
correctional supervision. Many researchers have found that such therapy can be an
effective means of treatment with outcomes similar to or even better than voluntary
substance abuse treatment (Anglin et al., 1998; Brecht, Anglin, & Dylan, 2005; Kelly,
Finney, & Moos, 2005; Staton-Tindall et al., 2009).
Anglin, Prendergast, and Farabee (1998) reviewed 11 studies published from
1976 to 1996 that examined the effectiveness of various levels of coercion (i.e., legal
pressure) for substance abuse treatment for drug-abusing offenders. Four of the studies
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found no differences in outcomes between individuals who entered into treatment under
some level of legal pressure and those who entered voluntarily or under minimal levels of
coercion (Anglin, Brecht, & Maddahian, 1989; Brecht & Anglin, 1993; McLellan &
Druley, 1977; Simpson & Friend, 1988). Five of the 11 studies reported finding greater
outcomes (e.g., completion rates, attendance, retention, criminality, and/or substance use)
for individuals who entered into treatment under some level of legal coercion when
compared to those who entered into treatment voluntarily (Collins & Allison, 1983;
Rosenberg & Liftik, 1976; Salmon & Salmon, 1983; Schnoll, Goldstein, Antes, &
Rinella, 1980; Siddall & Conway, 1988). For example, Collins and Allison’s (1983)
study of 2,276 individuals in outpatient and residential treatment programs found that
clients who were legally referred for treatment remained in therapy longer than did those
who did not experience legal pressure. Only two of the 11 studies reported finding worse
outcomes (e.g., compliance or retention) for those who entered into treatment under some
level of legal coercion when compared to those who entered voluntarily (Harford,
Ungerer, & Kinsella, 1976; Howard & McCaughrin, 1996). It is important to note that
the only statistically significant difference found by Harford et al. (1976) was that
treatment retention was poorer for older methadone clients and adolescents admitted to
treatment while on probation. No other statistically significant differences in retention or
completion rates (i.e., graduation of program) were found for any of the four measures of
legal pressure (being on probation, being on parole, awaiting trial, or a composite of three
previous groups). Howard & McCaughrin (1996) found that treatment organizations with
75% or greater court-mandated clients reported a statistically greater rate of clients failing

5

to follow the treatment plan. However, no statistically significant differences were found
for the completion of treatment goals between organizations with 75% or greater
mandated clients and organizations with 25% or fewer mandated clients. Results of
Anglin et al.’s (1998) review provide support for the claim that individuals who
experience legal pressure to enter substance abuse treatment generally experience
outcomes similar to or better than those of individuals who entered into treatment
voluntarily.
Four other studies (Brecht et al., 2005; Burke & Gregoire, 2007; Kelly et al.,
2005; Staton-Tindall et al., 2009) also found coerced treatment for substance abuse to be
effective. A study conducted by Brecht et al. (2005) found no statistically significant
differences on methamphetamine use outcome measures between those who felt
pressured to attend treatment from either the criminal justice system or child protective
services and those who did not perceive pressure. Staton-Tindall et al.’s (2009) study
examined substance use treatment outcomes for 700 offenders from Kentucky’s
corrections-based substance abuse modified therapeutic community treatment programs
using a pre-post design. Results revealed that a significantly smaller percentage of
participants reported any illicit substance use at follow-up than at baseline (43.9% versus
94.1%, respectively; p < .0001). Kelly, Finney, and Moos (2005) sought to examine
differences between the characteristics, treatment processes, and one- and five-year
outcomes for substance use disorder patients involved with the criminal justice system
and mandated to treatment (JSI-M), involved with the justice system and not mandated to
treatment (JSI), and not involved with the justice system (No-JSI). Overall, there were
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significant improvements during the course of treatment in coping, self-efficacy, and 12step group involvement. At one-year follow-up, participants in the JSI-M group were
significantly more likely to be abstinent (as measured by self-report and drug testing for a
subset of participants; p < .001), in remission (p < .001), and to not have encountered any
substance-related rearrests (p = .04) than members of both the JSI and No-JSI groups.
Burke and Gregoire (2007) also conducted a self-report study examining the relationship
between treatment coercion and post-treatment substance use and substance use severity
for men enrolled in outpatient programs throughout Ohio. Results revealed clients
coerced into treatment had lower substance use severity scores at 6-month follow-up than
did those participants who entered treatment voluntarily, controlling for pretreatment
substance use severity. Participants who were legally coerced into treatment also
reported less substance use at follow-up than did those who entered without legal
pressure.
Several noteworthy limitations are present in the aforementioned studies.
Participants were overall predominantly white males and assessment of motivation for
treatment was not included in two of the studies (Brecht et al., 2005; Staton-Tindall et al.,
2009). Staton-Tindall et al.’s (2009) study also did not include a comparison group or an
assessment of perceived coercion for treatment. With the exception of the study by Kelly
et al. (2005), all studies utilized only self-report measures of substance use. Despite the
limitations of the aforementioned studies, coerced substance abuse treatment for
offenders appears to produce treatment outcomes that are at least comparable to, if not
greater than, those of individuals who enter into treatment voluntarily.
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Group therapy for substance abuse. Group counseling is the most frequently
used treatment intervention for substance use disorders (Barlow, Burlingame, &
Fuhriman, 2000; Blume, 1985) in order to allow group participants to develop supportive
interpersonal relationships with others who have faced similar experiences, cultivate
socializing techniques, and learn to identify problematic behavior patterns and
appropriate coping strategies (Weiss, Jaffee, de Meni, & Cogley, 2004; Yalom, 2005).
Group therapy also provides a cost effective way to maximize therapeutic services.
Therapists are able to provide treatment to multiple clients in relatively the same amount
of time as an individual session.
Weiss, Jaffee, de Meni, and Cogley (2004) synthesized the research on group
treatment for substance use disorders, identifying three studies (Graham, Annis, Brett, &
Venesoen, 1996, Marques & Formigoni, 2001, & Schmitz et al., 1997) that directly
examined the effectiveness of group therapy compared to individual therapy. In each of
the three studies, no significant differences were found in treatment outcomes based on
the format of therapy. One study found that individuals in the group therapy condition
reported fewer days of cocaine use during treatment than did those participating in
individual therapy (Schmitz et al., 1997). Weiss et al. concluded that virtually identical
treatments for substance use disorders delivered in either an individual or group therapy
format generated no statistically significant differences on outcome measures. For
example, Schmitz et al.’s (1997) study of 32 cocaine-dependent participants assigned to
either a group-based or individually-based relapse prevention program found no
statistically significant differences between drug tests based on format of treatment nor
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any significant difference on cocaine use outcome measures. Individuals in the groupformat reported significantly fewer cocaine-related problems and significantly fewer days
of cocaine use during treatment than did participants who received individual therapy.
The authors concluded that relapse prevention treatment for cocaine abuse was effective
regardless of format.
Group therapy for offenders. Studies have started to evaluate the effectiveness
of group therapy formats for offender populations, yet results thus far have been
inconsistent (Morgan & Flora, 2002). A national survey of group therapy in state
correctional facilities reported an average of 20% of male inmates of responding
therapists received some type of group treatment. Of male inmates receiving group
therapy services, an average of 54% were referred by staff or mandated to attend
(Morgan, Winterowd, & Ferrell, 1999). Morgan and Flora (2002) identified 26 studies
meeting inclusion criteria for a meta-analysis of existing research examining the effects
of group psychotherapy with incarcerated offenders. Positive treatment effects were
found for group therapy compared to control conditions for the variables of institutional
adjustment (g = 0.43), anger (g = 0.45), anxiety (g = 0.94), depression (g = 0.57),
interpersonal functioning (g = 0.36), locus of control (g = 0.79), and self-esteem (g =
0.31). Whether an inmate was mandated to attend treatment or attended on a voluntary
basis was a non-significant predictor of effect size. For studies in which clients
volunteered for treatment, the weighted mean effect size was d = 0.68 (SE = 0.14) and for
studies in which clients were mandated to attend, the weighted mean effect size was d =
0.60 (SE = 0.22). The authors concluded that group psychotherapy treatment with
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offenders resulted in improvements of all outcomes assessed when compared to offenders
in control conditions (Morgan & Flora, 2002).
Despite the prevalence of research examining the effectiveness of coerced
substance abuse treatment for individuals under correctional supervision, a thorough
review of the literature failed to find any studies that examine the effect of a continuous
client feedback system on therapeutic outcomes with such a sample. Since previous
research has found the use of continuous client feedback to be an effective means for
improving psychotherapy outcomes for voluntary clients, an examination of the
effectiveness of monitoring coerced clients’ response to treatment and the therapeutic
relationship appears warranted. Such practice would also align with Garvin’s (1997)
third principle of group work with involuntary clients which encourages leaders to
involve the client in group-related decision making as much as possible. Prior to further
exploration of this particular gap in the literature, use of client feedback with voluntary
clients and the unique characteristics of therapy with coerced individuals will be
reviewed.
Client Feedback
Continuous outcome assessment, or client feedback, entails the use of a
psychotherapy outcome measure during each session of treatment, as opposed to the
usual pre-post therapy format (Lambert, 2001). In an era of accountability, the use of
client feedback to track progress and outcomes is consistently becoming a more common
practice in the field of psychotherapy and is considered to be a strategy for quality
improvement (Lambert, 2010). The client, clinician, parent, peer, or caregiver can
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complete the outcome measures, which can be either diagnosis-specific or more general
assessments of global functioning.
Despite the fact that psychotherapy is a highly effective means of treating clients
(Lambert, 2013), outcome studies also suggest that approximately 5-10% of clients
deteriorate in therapy (Lambert & Ogles, 2004; Lambert & Shimokawa, 2011) and
clinicians are generally unsuccessful at predicting treatment failure (Breslin, Sobell,
Buchan, & Cunningham, 1997; Chapman et al., 2012; Hannan et al., 2005; Yalom &
Lieberman, 1971). Additionally, clinicians generally over estimate the success of their
clients in the progression towards and attainment of treatment goals (Walfish, McAlister,
O’Donnell, & Lambert, 2012). Thus, the use of client feedback has become an effective
means of gathering information from the client on her or his perception of treatment
success or failure. By providing a real-time comparison to an expected treatment
response, clinicians can more accurately gauge client progress (Duncan & Reese, 2015).
With the monitoring of client perceptions on a regular basis, the opportunity is made
available to engage in open communication with the client regarding progress and to
better understand the client’s views of treatment. The use of such feedback measures
alerts therapists to client deterioration and signals when change is not occurring as
predicted, offering the opportunity to address the client’s concerns in a practical and
appropriate manner. Recognizing, acknowledging, and discussing the client’s
perceptions of treatment can potentially reduce instances of treatment failure (Reese et
al., 2009). The use of continuous client feedback has a well-established and increasing
evidence base for improving treatment outcomes with adults in individual, couple, and
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group therapy when compared to treatment-as-usual (Anker et al., 2009; Reese et al.,
2009; Reese et al., 2010; Schuman, Slone, Reese, & Duncan, 2015; Shimokawa,
Lambert, & Smart, 2010; Slone, Reese, Mathews-Duvall, & Kodet, 2015).
A positive alliance during therapy is found to be one of the best predictors of
successful outcomes, and the client’s perception of the therapeutic relationship is found
to be the most consistent predictor of client improvement (Bachelor, 1991; Gurman,
1977; Horvath & Symonds, 1991; Martin, Garske, & Davis, 2000). Second only to the
client’s own strengths and resources (e.g., social support, motivation to change), the
therapeutic alliance is considered to be the most consistent predictor of client outcome
(Duncan, Miller, Wampold, & Hubble, 2010; Horvath & Symonds, 1991; Lambert, 1992;
Lambert & Ogles, 2004; Martin et al., 2000; Wampold, 2001). The therapeutic alliance
is a partnership between the therapist and the client that is made up of three interrelated
elements, including the client’s sense of connection with the therapist, the client and
therapist’s agreement on the goals of treatment, and agreement between the client and
therapist on the tasks of treatment (Bordin, 1979). Thus, the frequent monitoring of the
client’s perception of the alliance and treatment outcome via the use of a continuous
client feedback system would appear to be a beneficial and informative practice.
Continuous assessment in therapy. Two commonly used continuous client
feedback systems, the Outcome Questionnaire System (OQ System; Lambert, Hansen, &
Harmon, 2010) and the Partners for Change Outcome Management System (PCOMS;
Duncan, 2012, 2014; Duncan & Sparks, 2010), are described below. Although there are
currently several formal feedback systems in the field (see Castonguay, Barkham, Lutz,
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& McAleavey, 2013), only the OQ System and PCOMS have been evaluated via
randomized clinical trial (RCT) design in the United States. Both feedback systems are
a-theoretical (i.e., common factors) and assess global functioning, as opposed to
diagnosis-specific concerns (Duncan, 2012).
Due to the significant improvements demonstrated in clinical settings, both
feedback systems have been included on the Substance Abuse and Mental Health
Services Administration’s (SAMHSA) National Registry of Evidence-Based Programs
and Practices (SAMHSA, 2012). Both feedback systems are also congruent with the
definition of evidence-based practice in psychology established by the Presidential Task
Force on Evidence Based Practice of the American Psychological Association (APA):
“[T]he integration of the best available research with clinical expertise in the context of
patient characteristics, culture, and preferences” (APA Presidential Task Force on
Evidence-Based Practice, 2006, p. 274). Further information on each system is provided
and reviewed below.
Outcome Questionnaire System (OQ System). Lambert and colleagues (1996)
were among the first in the field to develop and implement a formal system for obtaining
client feedback. The OQ System, which is composed of the Outcome Questionnaire-45
(OQ-45; Lambert et al., 2013), was developed to monitor client status and progress
during the course of therapy on domains including personal distress, difficulties in
interpersonal relationships, and problems related to one’s social roles. The OQ-45, which
is a 45-item measure of global distress that takes approximately 5-7 minutes to complete,
is generally administered to the client at the commencement of each therapy session.
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Scores can range from 0 to 180 with lower scores signifying less distress. The cutoff
score for the OQ-45 demarcating dysfunction/normal functioning is 63/64. The OQ
System also includes a signal alarm system that uses statistical algorithms to monitor
progress and alert therapists to instances when clients are not-on-track (NOT; i.e., at risk
for negative outcome or premature termination of therapy). If a client is identified as
being NOT, the Assessment for Signal Clients (ASC), a 40-item self-report measure
aimed at assessing the type and severity of problems that may be impacting treatment
progress, can be implemented. The items correspond to subscales regarding the
therapeutic alliance, client motivation and readiness for change, diagnostic formulation,
life events, need for medication referral, and social support. Subscales are associated
with corresponding recommendations for adjusting treatment to resolve identified
problems. The ASC is presented within the framework of the clinical support tools
(CST), which provide the therapist with a decision tree and possible interventions to aid
in problem solving and responsiveness to the client (Lambert, 2015).
Evidence for the efficacy of the OQ System is based on nine RCT studies, all of
which demonstrated significant treatment gains for clients identified as being NOT who
were in a feedback (FB) condition compared to those receiving treatment as usual (TAU;
Crits-Christoph et al., 2012; Harmon et al., 2007; Hawkins, Lambert, Vermeersch, Slade,
& Tuttle, 2004; Lambert et al., 2001; Lambert et al., 2002; Probst et al., 2013; Slade,
Lambert, Harmon, Smart, & Bailey, 2008; Simon et al., 2013; Whipple et al., 2003).
Shimokawa, Lambert, & Smart’s (2010) meta/mega-analysis evaluating the effects of the
OQ System was conducted with six of the earliest RCT studies, each of which examined
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the effects of providing feedback about each client’s (N = 6,151) improvement via the use
of progress graphs and a signal alarm system for NOT cases. When the odds of
deterioration and obtaining clinically significant improvement were compared,
individuals in the FB condition had 2.6 times higher odds of experiencing reliable
improvement (i.e., an improvement of at least 14 points) and less than half the odds of
experiencing deterioration compared to individuals receiving TAU. Estimated weighted
mean effect sizes were computed (Hedge’s g), with negative values indicating lower
levels of distress. The intent-to-treat (ITT) analyses comparing mean post-test OQ-45
total scores for those receiving feedback with those receiving TAU for individuals
identified as NOT resulted in the following aggregated between-group effect sizes: g = 0.28 (p < .01) when feedback was only provided to the therapist, g = -0.36 (p < .001)
when feedback was provided to both the therapist and the client, and g = -0.44 (p < .001)
when feedback was provided to the therapist along with CST. Additionally, the overall
percentages of clinically significant improvement for clients identified as NOT were:
30.9% when feedback was provided to the therapist only, 38.7% when feedback was
made available to both the client and the therapist, and 37.6% when feedback was
provided to the therapist and accompanied by CST.
Using the meta-analysis conducted by Shimokawa et al. (2010), Lambert and
Shimokawa (2011) further examined the efficacy of the OQ System by examining only
those clients who completed treatment (as opposed to the ITT sample). When NOT
clients in the FB condition were compared to clients in the TAU condition, the metaanalysis found a combined weighted random effect size for post-treatment OQ-45 score
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difference of r = 0.25 (g = 0.53; p < .001). The meta-analysis also found the average
client at-risk for treatment failure (i.e., NOT) whose clinician received feedback was
better off than approximately 70% of NOT clients whose therapist did not receive
feedback. At termination, 9% of clients in the FB conditions deteriorated during
treatment, as opposed to 20% in the TAU condition. Additionally, at termination 38% of
those identified as being NOT in the FB condition obtained clinically significant change
(i.e., reliable change that includes moving from the clinical range to the nonclinical
range), while only 22% from the TAU condition clinically significantly improved.
Despite the documented success of the OQ System in helping to improve clinical
outcomes for clients who are identified as being NOT, therapists have noted that the
amount of time needed to administer and score the OQ-45 has resulted in them not using
it frequently in the therapy setting. In addition, both clients and therapists have voiced
concerns that many of the items on the measure are not relevant or pertinent to the
reasons the client was attending therapy (Duncan, Miller, & Sparks, 2004). In an attempt
to remedy the concerns voiced by clients and therapists alike, a briefer, more feasible
outcome system was developed.
Partners for Change Outcome Management System (PCOMS). Duncan, Miller,
and Sparks (2004) maintain that to obtain the valuable information from the client
regarding her or his perception of treatment progress and the therapeutic alliance on a
regular basis requires fervent attention to the client’s goals, as well as the flexibility of
the therapist to alter treatment based on ongoing assessments of the client’s perception of
whether or not treatment is advancing in an expected and positive direction. This
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particular insight, coupled with a desire to address the concerns of the OQ System, helped
to facilitate the development of a client-directed outcome-informed (CDOI) approach to
treatment in which it is the client, not a specific model or intervention, that guides the
therapy process. The Partners for Change Outcome Management System (PCOMS;
Duncan, 2012, 2014; Duncan & Sparks, 2010) is a continuous client feedback system that
helps to meet the goals of a CDOI approach to therapy. PCOMS was developed to help
reduce client dropout and deterioration in therapy, as well as improve client outcomes.
PCOMS is composed of the Outcome Rating Scale (ORS; Miller & Duncan, 2000) which
measures the client’s well-being and the Session Rating Scale (SRS; Miller, Duncan, &
Johnson, 2002) which measures the client’s perception of the therapeutic relationship.
According to Sparks, Duncan, and Miller (2008), the undeniable link between the
client’s positive ratings of therapist provided variables (i.e., warmth, professionalism, fit
with the views and expectations of the client) and improved psychotherapy outcomes
makes a strong case for a focus on fitting the therapy process to the client’s perceptions
of a positive relationship. Knowing the client’s perception of the treatment process and
the therapeutic relationship is a key component in improved psychotherapy outcomes,
routinely collecting and reviewing information from the client regarding both is
warranted. PCOMS aims to privilege the voice of the client during therapy and enables
the client to share her or his views of treatment progress with the therapist.
Despite having much briefer measures of client outcome and therapeutic alliance
than the OQ System, PCOMS has also demonstrated its efficacy in clinical settings for
individuals (Reese et al., 2009), couples (Anker et al., 2009; Reese et al., 2010), and
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groups (Schuman et al., 2015; Slone et al., 2015). Reese, Norsworthy, and Rowlands
(2009) conducted RCTs in two sites to replicate the findings of Miller et al. (2006). The
sample for study one was 74 clients, the majority of whom identified as White and
female, who attended individual therapy at a university counseling center. The sample
for study two was also 74 clients, the majority of whom also identified as White and
female, who attended individual therapy at a graduate training clinic for a marriage and
family therapy master’s program. In the first study, participants were assigned to either a
FB or TAU condition using a randomized block design to help control for therapist
effects. For study one only, clients in the FB condition completed the ORS at the start of
each session and the SRS at the conclusion of each session. Participants in the TAU
condition completed the ORS only at the beginning and end of treatment, not at each
session. Protocol for study two differed in two primary ways: (1) participants in the
TAU condition completed the ORS at the start of each session of treatment (as opposed
to only at the first and last session), and (2) therapists, rather than clients, were randomly
assigned to the FB or TAU condition so as not to trouble beginning marriage and family
therapy practicum students with the task of alternating between two therapy protocols.
Results of the studies indicated that clients in the FB condition reported greater
improvement than did those in the TAU condition. Individuals in both treatment
conditions showed statistically significant improvement on pre and post measures of the
ORS. In both studies the FB condition showed roughly twice as much improvement as the
TAU condition (study one: 12.69 points vs. 6.82 points; study two: 10.83 vs. 4.69
points). Reese et al. (2009) found medium to large effect sizes according to Cohen’s
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(1988) standards for the FB condition (study one: d = 0.54; study two: d = 0.49).
Additionally, analyses of data from study two revealed that clients in the FB condition
were estimated to achieve reliable change (at least a 5 point improvement on the ORS) in
fewer sessions than those in the TAU condition. Clients in the FB condition also
demonstrated statistically significant higher rates of reliable change than did clients in the
TAU condition (study one: 80% versus 54.2%; study two: 66.67% versus 41.4%). This
finding indicates that all clients in the FB condition, not just those clients identified as
being NOT for reliable change, benefited significantly from therapy with PCOMS when
compared to controls (Reese et al., 2009).
Two RCT studies (Anker et al., 2009; Reese et al., 2010) have also demonstrated
PCOMS’ efficacy in improving outcomes for couples’ therapy. Anker, Duncan, and
Sparks (2009) evaluated treatment outcomes of 205 couples assigned to either a FB or
TAU condition. The effect size for the difference between the FB condition and TAU
condition was d = 0.50. Over twice as much improvement was noted on the ORS for
couples in the FB condition when compared with those in the TAU condition (8.27 vs.
3.11 points). Additionally, nearly four times as many couples in the FB condition
obtained clinically significant change (reliable change that includes moving from the
clinical range to the non-clinical range); effects were maintained at 6-month follow-up
with in the FB condition significantly more likely to be together. The aforementioned
findings were replicated by Reese, Toland, Slone, and Norsworthy’s (2010) study of 46
couples assigned to either a FB or TAU condition. The standardized mean effect size
between treatment conditions was d = 0.48. Participants in the FB condition
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demonstrated over twice as much improvement on the ORS (8.58 vs. 3.64 points). As
with the previous study, nearly four times as many couples in the FB condition achieved
clinically significant change compared with those receiving TAU. Additionally, clients
utilizing PCOMS during therapy improved at a faster rate.
Lambert and Shimokawa’s (2011) meta-analysis examined the overall efficacy of
PCOMS by reviewing three RCT studies (Reese et al., 2009; Anker et al., 2009). The
analysis produced a combined weighted random effect size of r = 0.23 (p < .001) for posttreatment scores of clients in the FB condition compared to clients receiving TAU.
Results were comparable to research on the OQ System in which the combined effect size
for the earliest six studies was r = 0.25 (p < .001). Furthermore, when the odds of
obtaining reliable improvement over the odds of not achieving reliable improvement
were compared across conditions, individuals in the FB group had 3.5 times higher odds
of experiencing reliable change and less than half the odds of experiencing deterioration
(Lambert & Shimokawa, 2011).
Continuous assessment in group therapy. Evidence for the efficacy of
continuous client feedback within group psychotherapy settings is emerging. Though
feedback systems are theoretically posited to be effective in a group setting (Dies & Dies,
1993), results are decidedly mixed (Davies, Burlingame, Johnson, Gleave, & Barlow,
2008; Schuman et al., 2015). Research examining the use of a client feedback system in
such a setting is reviewed below.
Davies, Burlingame, Johnson, Gleave, and Barlow (2008) examined the effect of
client feedback on group process and outcome with group therapy clients at a university
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counseling center. Participants (N = 94) made up 16 psychotherapy groups that were
randomly assigned to either a FB or TAU condition. Participants completed the Curative
Climate Instrument (CCI; Fuhriman, Drescher, Hanson, & Henrie, 1986) and the Group
Climate Questionnaire - Short version (GCQ-S; MacKenzie, 1981) at the end of each
group session. Participants in the FB condition (both leaders and group members) were
provided with a tally of the responses to the GCQ-S, which provides information on
members’ sense of engagement, avoidance, and conflict. The OQ-45 (Lambert et al.,
1996), which served as the outcome measure, was completed at the start and conclusion
of treatment. Analyses found no significant difference in outcome or engagement
between the two conditions. The authors speculated that even though the group members
received general information regarding the group climate, the lack of specific information
about themselves or others in the group provided only limited opportunity to gain
interpersonal insight and information (Davies et al., 2008).
The efficacy of PCOMS for group therapy has also been evaluated. In the group
format, the ORS is administered to all clients at the start of each session and the Group
Session Rating Scale (GSRS; Duncan & Miller, 2007) to all clients toward the conclusion
of each session. As with the individual format, scores for each measure are totaled and
charted to track progress.
A 2015 study by Schuman, Slone, Reese, and Duncan evaluated the efficacy of a
modified version of PCOMS with soldiers referred for group substance abuse treatment.
Participants, who were primarily referred for treatment in the program by their
commanding officer following some type of alcohol or drug-related problematic behavior,
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were randomly assigned to either a group FB condition (n = 137) or a group TAU
condition (n = 126). Participants completed a computerized version of the ORS prior to
each process group session. The GSRS was not utilized in this study as it had not yet been
developed at the time of data collection. Therapist and commander outcome ratings were
also obtained during a rehabilitation team meeting after completion of the soldier’s last
therapy session. Controlling for pretreatment functioning, an ANCOVA found a
significant difference in post-ORS scores between treatment conditions (p = .011),
indicating that the FB condition demonstrated larger treatment gains than the TAU
condition. A small-to-medium effect size (d = 0.28) was found for feedback. Further,
effects were found for all clients in the FB condition, not just those noted to be NOT or at
risk for negative treatment outcomes. Additionally, individuals in the FB condition also
attended more therapy sessions and were less likely to terminate prematurely compared
with those in the TAU condition.
Slone, Reese, Mathews-Duvall, and Kodet (2015) utilized a randomized cluster
design (in which groups as a whole were randomly assigned to a treatment condition) to
evaluate the efficacy of PCOMS in a group psychotherapy format. Group therapy
participants (N = 84) were assigned to either a FB condition (n = 43) or a TAU condition
(n = 41) at a university counseling center. Participants attended an interpersonal process
therapy group for social anxiety and interpersonal concerns. Those in the FB condition
completed the ORS at the start of every session and the GSRS at the conclusion of each
session. Participants in the TAU condition completed the ORS at the start of every
session, but leaders were not provided access to members’ progress and leaders were
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instructed not to prompt any discussion of the measures. As in the aforementioned study
evaluating PCOMS in a group setting, statistically significant pre-post treatment gains
were found for feedback when compared to TAU; however, the magnitude of change for
the Slone et al. study was slightly larger than that observed in the Schuman et al. (2015)
study (d = 0.41 vs. d = 0.28). The authors posited the differences might partially be
attributable to use of the GSRS and length of group intervention. Participants in the Slone
et al. (2015) study attended an average of 10 weekly 1.5- hour sessions compared with an
average of 3.86 sessions of the same length for the Schuman et al. (2015) study. Although
the results yielded a medium group effect size (Cohen, 1988), the effects of feedback in
group settings appear to be more modest than from RCTs using PCOMS for individuals (d
= 0.49 and d = 0.54; Reese et al., 2009) and couples therapy (d = .50 and d = .54; Anker et
al., 2009; Reese et al., 2010). Results indicated more clients in the FB condition than in
the TAU condition obtained reliable change (32.6% vs. 17.1%) and clinically significant
change (41.9% vs. 29.3%) on the ORS. Clients in the FB condition also attended a higher
number of sessions compared to those in the TAU condition (10.4 vs. 9.6). No
statistically significant differences were found between treatment conditions on premature
termination rates.
Various research studies have demonstrated that the use of continuous client
feedback has proven effective in the reduction of premature termination and improved
treatment outcomes. Significant findings such as the ones described above have resulted
in the APA’s Task Force for Evidence-Based Practice in Psychology (2006)
recommendation that practice include the monitoring of treatment outcomes.
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Despite the documented success of client feedback systems in improving
treatment outcome, a thorough search of the client feedback literature failed to identify
any studies that address the use of a continuous feedback system with offenders who have
been referred or coerced to attend therapy. The improved outcomes resulting from the
use of a continuous client feedback system with voluntary clients, as well as the unique
characteristics of work with individuals coerced to treatment, warrants an examination of
the effectiveness of feedback with involuntary clients.
Characteristics of Coerced Psychotherapy
Two particularly salient characteristics of psychotherapeutic work with
involuntary clients include the referred individual’s potential resistance to treatment and
motivation for therapy. As will be reviewed below, both can undermine treatment.
Client resistance. The majority of authors in the field agree that involuntary
clients generally enter into therapy with a greater degree of resistance than clients who
seek services voluntarily (Rooney, 2009; Slonim-Nevo, 1996; Snyder & Anderson, 2009;
Storch & Lane, 1989). Resistance, which is considered by Norcross (2010) to be a
reaction that is characterized by high defensiveness and responding in an oppositional
manner to external demands, is a potential response for any individual who is forced or
coerced into a situation. Resistance, which is a barrier to the process of eliciting change
in clients, is postulated to be more likely to occur when an individual perceives a loss of
freedom of choice (Moyers & Rollnick, 2002). Thus, resistance frequently manifests in
work with non-voluntary and legally mandated clients who potentially perceive their
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freedom of choice regarding the use of treatment to have been violated. The involuntary
and resistant client is described by Storch and Lane (1989):
At the time when the mandated client appears at the Center, he is generally very
upset and agitated. He has likely just had some sort of difficulty which has
brought him to the attention of some agency of society – court, probation or
parole office, the police, child protection, school, and so forth. Generally the
agency has taken a look as the situation and has decided that “treatment” would
be an effective part of the intervention. On the basis of this decision the person is
sent to an agency, center, or clinic of one sort or another. He comes grudgingly,
angry at the authority that “remanded” him to the Center, and hardened and
reinforced in his anger and defiance. Like the apocryphal child who, as low man
in the family hierarchy kicks the dog, the mandated patient feels put upon and
aggrieved, and lashes out at the available target (p. 30).
Resistance is often considered to be a typical and fundamental response, as
opposed to an indicator of pathology, for any individual who is coerced into
psychotherapy treatment and who is consequently experiencing a perceived loss of
freedom, independence, and choice (Moyers & Rollnick, 2002; Rooney, 2009; Snyder &
Anderson, 2009; Storch & Lane, 1989). Due to the normative nature of the concept,
Rooney (2009) considers resistance to instead be a label applied by practitioners to
clients who do not behave or act to the clinician’s satisfaction. Moyers and Rollnick
(2002) echo this belief by considering resistance to be a product of the interaction
between the client’s attitudes and reaction to treatment and the clinician’s attitudes and
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reactions to those of the client. Thus, resistance potentially becomes a therapist variable
as well as a client variable in involuntary treatment (Moyers & Rollnick, 2002).
Several authors consider resistance to be such a normative reaction to an
oppressive environment that they have renamed the term reactance in order to better
capture the role the context of treatment plays in the client’s noncompliance (Beutler,
Harwood, Michelson, Song, & Holman, 2011; Brehm & Brehm, 1981; Robinson &
Davis-Kennington, 2002). Brehm and Brehm (1981) theorized reactance inevitably
results as a means by which to counteract one’s perceived loss of autonomy and choice.
Client motivation. Another important client factor in involuntary psychotherapy
is the client’s level of motivation, defined broadly as that which moves the client to act
(Ryan, Lynch, Vansteenkiste, & Deci, 2011). Researchers in the field not only consider
involuntary clients to have higher levels of resistance or reactance than voluntary clients,
but also to have lower levels of motivation and initial readiness for change (Rooney,
2009; Slonim-Nevo, 1996; Snyder & Anderson, 2009; Storch & Lane, 1989). Motivation
is considered to be a primary factor relevant to issues of dropout, treatment compliance,
and maintenance of change in therapy (Drieschner, Lammers, & van der Staak, 2004;
Overholser, 2005; Ryan & Deci, 2008). One particular model of motivation that has
specific applicability to psychotherapy is the transtheoretical model, which posits
behavior change occurs over time as the individual progresses through a series of stages
of change (Prochaska & DiClemente, 1986; Prochaska, DiClemente, & Norcross, 1992).
The “stages of change were formulated as a fundamental part of a transtheoretical therapy
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model which has been developed as an integrative model of change for the fragmented
field of psychotherapy” (McConnaughy, Prochaska, & Velicer, 1983, p. 368).
Transtheoretical model of motivation to change. The transtheoretical model of
motivational readiness to change views the construct of motivation as existing along a
continuum or in a spiral pattern, rather than as a dichotomy (Prochaska & DiClemente,
1986; Prochaska et al., 1992). The concept of readiness to change generally indicates a
willingness of the client to adopt a particular behavior and has been conceptualized as a
combination of the clients’ perceptions of the importance of the problem and the clients’
confidence in their ability to change (Miller & Rollnick, 2002; Rollnick, Mason, &
Butler, 1999). Five stages of motivational readiness exist and include: (1)
precontemplation (the client does not acknowledge a problem exists or is under-aware
that a problem exists, and thus has no desire to change), (2) contemplation (the client is
aware a problem exists and is seriously contemplating changing, but has not yet taken
action), (3) preparation (the client is seriously considering changing in the next month
and has perhaps taken small preparatory steps), (4) action (the client modifies her or his
behavior, experiences, and/or environment), and (5) maintenance (the client works to
prevent relapse). Each stage of the model specifies motivational demands “by
segmenting the change process into specific tasks to be accomplished and goals to be
achieved, if movement toward successfully sustained change is to occur” (DiClemente,
Schlundt, & Gemmell, 2004, p. 104). Although individuals progress through the five
stages at various rates, the tasks and goals of each stage of change are invariant. The
stages of change (representing when people change), processes of change (representing
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how people change), decisional balance, and levels of attribution (to what the client
attributes the problems) are the primary components of psychotherapy and behavior
change (Brogan, Prochaska, & Prochaska, 1999; Prochaska & DiClemente, 1982, 1984,
1992).
Stages of change as predictor of treatment outcome. Research has demonstrated
that the stages of change and processes of change can reliably predict treatment outcomes
in psychotherapy for a variety of presenting problems (Polaschek, Anstiss, & Wilson,
2010), as well as predict treatment attendance (Prochaska, Norcross, Fowler, Follick, &
Abrams, 1992) and treatment termination (Brogran et al., 1999). Pretreatment motivation
has also been found to predict the client’s engagement and retention in treatment (Joe,
Simpson, & Broome, 1998). A study conducted by Brogan et al. (1999) revealed that
static client demographic characteristics (e.g. gender, age) were not significant predictors
of termination or continuation of therapy, but the transtheoretical stages of change,
processes of change (i.e., activities used by individuals to alter problem behaviors;
Prochaska, Velicer, DiClemente, & Fava, 1988), and decision-making variables (i.e.,
factors that influence one’s opinions of entering into therapy) were able to reliably
predict one’s therapy status. Results indicate 75%, 69.2%, and 52.2% of clients in each
category were correctly classified as premature terminators, appropriate terminators, or
continuers of therapy, respectively. Individuals who terminated therapy prematurely
exhibited high precontemplation scores and low scores on the other stages of change.
Individuals in the appropriate termination group demonstrated high scores on the action
scale, while participants in the continuation group exhibited high scores on the
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contemplation and maintenance scales with lower scores on the precontemplation and
action scales. When the appropriate termination and therapy continuer groups were
combined, results indicated 97.2% of participants were correctly classified in the
composite group and 83.3% were correctly classified as premature terminators (Brogan et
al., 1999).
Norcross, Krebs, and Prochaska’s (2011) meta-analysis of 39 studies revealed an
effect size d = 0.46 for the ability of the client’s pretreatment stage of change to predict
treatment outcome. The medium effect revealed by the meta-analysis indicated that the
amount of client progress during treatment tends to be a function of the client’s readiness
to change. The authors further analyzed the effect sizes of the stages of change based on
specific diagnostic categories: eating disorders, mood disorders, and addictions. For the
14 studies predicting addiction outcomes using pretreatment readiness to change, the
mean effect size was d = 0.37 (95% CI = 0.23-0.52, p < .001).
Motivation for change models and coerced clients. Research has only recently
started to examine the application and utility of readiness for change models for coerced
and incarcerated client samples (Hiller et al., 2009). Results of initial studies have
suggested, “treatment motivation also may be a predictor of retention, engagement, and
outcomes from corrections-based treatment” (Hiller et al., 2009, p. 30). Broome, Knight,
Knight, Hiller, and Simpson’s (1997) study of 250 individuals on probation who were
mandated by courts to a substance abuse treatment facility found that individuals’
recognition of drug related problems, as measured by client self-report and counselor
ratings, was positively associated with therapeutic relationships during treatment. Good
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therapeutic relationships were negatively associated with rearrest (Broom, Knight,
Knight, Hiller, & Simpson, 1997). Research conducted by Hiller, Knight, Leukefeld, and
Simpson (2002) with probationers mandated to residential substance abuse treatment
found that clients’ desire for help and readiness for treatment were positively associated
with indicators of therapeutic engagement, including higher levels of personal
involvement and higher ratings of personal progress. Other research has found a
significant direct relationship between client pretreatment motivation, voluntary entry
into aftercare services following release from prison, and reductions in reoffending and
drug use (De Leon, Melnick, Thomas, Kressel, & Wexler, 2000).
Clients falling into the precontemplation stage of the transtheoretical model of
motivational readiness to change are most likely to be clients who were sent for therapy
because of external pressure (i.e., force from others) (Prochaska et al., 1992). Thus,
based on the previously provided descriptions of involuntary clients, most would
theoretically fall into the category of precontemplation. DiClemente and Hughes (1990)
have found precontemplators to be less motivated to change than are clients in the action
and maintenance stages and precontemplators have also been found to be less likely to
develop a strong therapeutic alliance during the course of treatment (Connors et al.,
2000). Larke (1985) claims that successful work with involuntary clients is predicated on
the ability of the therapist to not give up on the relationship with the client due to her or
his resistance or lack of motivation. Snyder and Anderson (2009) theorize a lack of
motivation is potentially a normal and expected reaction for precontemplators forced into
treatment who experience a double bind when acknowledging a problem exists.
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McConnaughy, Prochaska, and Velicer’s (1983) initial work on the stages of
change in psychotherapy produced seven major and two minor client profiles, including
the Reluctance cluster. Individuals falling into this particular category generated close to
average scores on Pre-Contemplation and Contemplation, with Maintenance scores
falling below average and Action scores falling “extremely below average” (p.373). The
authors concluded that individuals categorized in this minor cluster are unwilling to take
action on the problem, although there may be some acknowledgement that a problem
does, in fact, exist. Individuals in the Reluctance profile do not exhibit any commitment
to change. Individuals comprising the Reluctance category were speculated to have
entered into treatment because of family, employer, or legal pressures rather than for
internal motivation to change. The authors hypothesized that such clients would be more
likely to prematurely terminate therapy or, if they do continue, would be resistant during
the treatment process.
Larke (1985) maintains motivation for treatment does exist in the involuntary
client, but perhaps in a manner that is different and more vague from the motivation in
the client who voluntarily seeks treatment. It is recommended that the therapist ask for
what is the involuntary client motivated as opposed to whether or not the involuntary
client is motivated. For example, when working with a client who was ordered to
counseling for driving while intoxicated, the client’s motivation may be to simply get her
or his driver’s license back after it was revoked. Though this goal or form of motivation
is likely not ideal in the eyes of the clinician and the referring agency who would
undoubtedly prefer more meaningful behavior change (i.e., no longer driving while
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intoxicated), the client’s goal nonetheless serves as a source of motivation. Wampold et
al.’s (1997) meta-analysis of outcome studies attributes 87% of improvement during
therapy to client variables, which include motivation and readiness to change.
Statement of the Problem
Because of the strong empirical support for the use of client feedback with
voluntary individuals and the unique characteristics and circumstances that underlie
coerced treatment with offenders, it appears the use of a formal system for monitoring
outcome and alliance would be imperative. However, as previously mentioned, a
thorough search of the client feedback literature failed to find studies that have assessed
the effectiveness of using a continuous client feedback system, specifically PCOMS, with
a sample of offenders who have been referred to attend treatment. The aforementioned
study conducted by Schuman et al. (2015) found a small-to-medium effect size (d = 0.28)
for feedback when a modified version of PCOMS was utilized for soldiers referred to
group substance abuse treatment. Based on the positive results shown with voluntary
clients and the results of the Schuman et al. (2015) study with referred soldiers, it appears
a study examining the effects of feedback for referred offenders would be warranted. It is
hypothesized that the use of a continuous feedback system with clients referred to
treatment by the criminal justice system would help to privilege their voices and provide
them with a sense of power and self-determination in an environment in which they
otherwise potentially experience feelings of coercion and a perceived loss of autonomy.
When involuntary clients experience resistance and decreased motivation for treatment,
the use of a feedback system in which their views and perceptions are prioritized could
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potentially result in increased motivation and readiness for change, as well as better
therapeutic outcomes. Client feedback offers the possibility of improving referred
clients’ treatment motivation and readiness for change through the continuous monitoring
of outcome and alliance. It is hypothesized that such a process would improve client
engagement in therapy, and consequently motivation for treatment and therapeutic
outcomes.
Based on the importance of the client’s perceptions of treatment outcome, it is
strongly recommended that research in the field focus on the effectiveness of continuous
client feedback measures with this particular population of clients. It is believed that by
providing ongoing and direct feedback to the therapist, the client will experience
increased treatment gains and lower rates of dropout or deterioration.
A unique opportunity exists within the Georgia State Board of Pardons and
Paroles to address this particular gap in the literature. Because the Parolee Substance Use
Recovery Program currently employs a continuous outcome assessment system
(PCOMS) and collects data from group members during each session (via the ORS and
GSRS), this study offers the possibility to add to the forensic psychological literature by
evaluating the effectiveness of a substance abuse treatment program for offenders
referred to attend.
Purpose of the current study and research questions. The purpose of the
present study was to evaluate the effectiveness of an outpatient substance abuse treatment
program for parolees that utilizes a continuous client feedback system as a quality
improvement strategy. The current study implemented benchmarking methodology to
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evaluate the effectiveness of services provided to parolees who have been referred to
attend outpatient substance abuse treatment at a Georgia State Board of Pardons and
Paroles counseling program that implements PCOMS.
Utilizing the most up-to-date benchmarking methodology (Minami, Serlin,
Wampold, Kircher, & Brown, 2008), the present study seeks to examine the following
research question: in comparison to efficacy trial benchmarks, is group psychotherapy
utilizing continuous client feedback (i.e., PCOMS) effective among parolees who have
been referred to attend treatment? Following guidelines presented in previous
benchmarking studies (e.g., Minami, Wampold, Serlin, Kircher, & Brown, 2007), results
from clinical trials will be used to construct treatment group and control group
benchmarks (i.e., separate aggregated effect size estimates for clients receiving treatment
or in a TAU condition, respectively). The effectiveness of group treatment provided to
parolees will be evaluated by comparing the observed pre-post effect size estimate
against the established efficacy benchmarks. It is hypothesized that the treatment
provided to parolees in the corrections-based setting will be equivalent to treatment
efficacy observed in clinical trials and superior to TAU.
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Chapter Two: Method
The present study is an evaluation of the effectiveness of a group substance abuse
program that incorporates continuous client feedback into treatment for parolees who
have been referred to attend by the Georgia State Board of Pardons and Paroles. In this
chapter, the current sample will be detailed and the procedures and treatment outcome
measure will be reviewed. Benchmarking methodology, as well as the construction of
the specific benchmarks, will then be described. Next, a detailed description of the data
analyses, including the calculation of effect sizes and benchmarking procedures will be
provided. Lastly, each hypothesis will be specified.
Design
The current naturalistic study utilized a benchmarking design to evaluate the
effectiveness of a corrections-based program utilizing a continuous client feedback
system with parolees who have been referred for substance abuse treatment.
Benchmarking allows for the direct statistical comparison of pre-post outcome data
obtained from non-controlled, naturalistic settings with rigorous and reliable outcome
standards observed in single clinical trials or meta-analyses of clinical trials (Minami et
al., 2007; Minami, Serlin, et al., 2008; Weersing & Weisz, 2002). Effectiveness of a
particular treatment is established by assessing whether the benefits to clients in a natural
setting approach the benefits obtained by clients in clinical research. Benchmarking
methodology allows for this evaluation without altering any aspects of the treatment
delivered in the clinical setting (Minami, Wampold, et al., 2008). The magnitude of
change observed in clinical trials (efficacy studies) is used as a benchmark against which
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the magnitude of change observed in the naturalistic setting is judged (Wade, Treat, &
Stuart, 1998).
Benchmarking methodology from Weersing and Weisz (2002) and Minami,
Serlin, Wampold, Kircher, and Brown (2008) was used to guide the present study.
Methodology was advanced in several ways by the work of Weersing and Weisz (2002).
The treatment being offered in the naturalistic setting was not altered during evaluation,
which allowed for the results to be generalized to TAU in the same setting. The authors
also utilized a benchmark effect size derived from the meta-analysis of multiple studies,
as opposed to only a single or a few studies, in order to provide a more comprehensive
and thorough comparison. A wait-list/control benchmark was also established in order to
compare treatment to the natural history or remission of symptoms over time. Lastly, the
authors evaluated whether the effect size from the naturalistic setting fell within the twotailed 95% confidence interval of the clinical trial based benchmark effect size. This
provided for a more rigorous comparison than previous methodology that simply
subjectively compared the two values. A further advancement by Minami, Serlin, et al.
(2008) included the use of the “good-enough principle” (Serlin & Lapsey, 1985, 1993),
which establishes a relevant margin between the effect size from the naturalistic setting
and the established benchmark. This statistical criterion for equivalence prevents one
from obtaining statistical significance with clinically trivial differences. The
aforementioned advances in methodology have allowed for the analysis of other data sets,
including the one utilized for the present study.
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Effect size (ES) estimates were calculated for the present sample of referred
offenders and then compared against benchmarks (i.e., TAU and ITT) constructed from
clinical trials examining the efficacy of continuous client feedback. Effectiveness studies
are conducted in naturalistic settings with effects for pre-post change typically being
based on all clients in treatment, as opposed to only those who completed treatment.
Thus, the conditions are more comparable to ITT ESs from efficacy research, which
include all participants who were initially randomized into conditions and not just those
who completed the treatment protocol (i.e., treatment completers). Additionally, because
naturalistic settings rarely offer the opportunity for comparisons to a no-treatment control
group, due to practical and ethical reasons, the use of a treatment as usual group
benchmark will allow for effectiveness testing with a comparison group (Minami et al.,
2007).
Procedures
The Institutional Review Board (IRB) at the University of Kentucky approved the
present study through an expedited review process on June 24, 2015. The Georgia State
Board of Pardons and Paroles (GSBPP), which contracts with Spectrum Health Systems
(SHS), a private, not-for-profit organization that provides mental health and substance
abuse services, provided pre-existing treatment outcome data. Through their partnership,
the GSBPP and SHS provide weekly outpatient group psychotherapy for individuals
across the state of Georgia who have been referred by the criminal justice system to
substance abuse treatment (risk-based referral from the individual’s parole officer).
Individuals who are referred to treatment attend an initial 90-minute intake group session
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referred to as Motivation Assessment and Planning (MAP). During the initial session,
group members assess personal risk and need factors, as well as set goals and tasks for
the remaining sessions. Following completion of the initial session, the individual is
placed in a Recovery Action and Progress (RAP) group that meets weekly for 60
minutes. RAP groups, which include a maximum of 10 participants, are based upon the
“what works (i.e., evidence-based practices)” literature for offender rehabilitation.
Groups are cognitive-behavioral in design and consist of motivational assessment and
planning. Sessions focus on discussing and processing one’s progress, goals, resources,
and barriers. In order to successfully complete the Parolee Substance Use Recovery
Program, participants must attend at least six consecutive RAP group sessions and obtain
at least two consecutive negative drug screens. SHS included PCOMS in the treatment of
all parolees involved in this study.
Treatment providers utilized PCOMS comprehensively across the state,
administering the ORS at the commencement of each session and the GSRS at the
conclusion of each session. Group leaders were trained in administration of the measures
via a 6-8 hour in-person training and follow-up PCOMS webinars. In regards to
continuous quality improvement strategies, clinicians received written feedback from a
clinical supervisor who observed a group session. Observations were conducted in order
to help ensure fidelity to PCOMS protocol, as well as to address any concerns or
questions regarding group administration or use of the feedback system. Feedback
occurred quarterly to annually, depending on the clinicians’ experience and competence
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(as deemed by the supervisor). Clinicians (N = 55) were predominantly female (81.8%).
No additional information was provided regarding clinicians’ demographics.
Participants
For the present study, SHS and the GSBPP granted permission for data analysis of
parolees who attended substance abuse treatment across the state of Georgia between
October 2014 and January 2015. The initial dataset included 3,250 cases, to which the
following deletions were made: (a) 944 cases in which only one session was attended,
thus not allowing for the calculation of a pre-post change score, (b) 577 cases in which
the individuals started treatment too late during the time period to complete the
requirements, (c) 607 cases in which the individuals started treatment prior to the time
period for which data was provided, thus an initial (pretest) score was not available, and
(d) ten cases in which the individuals were discharged from the program by the parole
officer (due to a transfer or the completion of the parole term). In order to be included in
the analysis, the individual had to attend at least two sessions, with the first being the
MAP intake session, in order to calculate a pre-post change score. Of the 607 cases in
which treatment was started prior to the time period for which data were provided, 269
cases included a REC 1 score, but not a MAP score. Please see the Preliminary Analyses
section of the Results chapter for a comparison regarding ORS scores for those with a
MAP score at pretest and those with a REC 1 score at pretest. Consistent with guidelines
utilized by Reese, Duncan, Bohanske, Owen, and Minami (2014), if clients re-entered
treatment, only the first observation was included in analyses. As some benchmarking
studies only utilized clients in analyses who had an initial intake score in the clinical
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range (e.g., Minami et al., 2009; Stiles, Barkham, Connell, & Mellor-Clark, 2008), the
present study included clients whose functioning at intake (i.e. the MAP session) was in
the non-clinical range. This was consistent with methodology utilized by Reese et al.
(2014) and allowed for the data set to be more representative of individuals referred for
treatment in the Parolee Substance Use Recovery Program.
After the aforementioned deletions were made, the final dataset contained 1,112
individuals. Please see Table 1 for complete sociodemographic information of the
present sample. The majority of individuals in the final dataset were African American
(49.6%), male (82.9%), employed (54.1%), unmarried (65.9%), and ranged in age from
18 to 68 years (M = 35.42, SD = 10.22). Additionally, in regards to education, the
majority of participants had at least completed high school or obtained a GED (45.0%).
Of those who had not yet completed high school or obtained a GED, 84.80% (n = 385)
had completed at least the ninth grade. Parolees were conditionally released from
incarceration to serve the remainder of the sentence in the community. Of those
individuals included in the final dataset, 34.9% had been incarcerated for a drug related
offense (i.e., drug possession, possession with intent to distribute, drug trafficking,
sale/distribution of a controlled substance), making it the most common offense category.
All individuals included in the present study participated in the Parolee Substance Use
Recovery Program between October 2014 and January 2015. Of those who participated
in treatment, 48.9% (n = 544) successfully completed the program (i.e., attended at least
six consecutive group therapy sessions and obtained at least two consecutive negative
drug screens). Individuals who had to restart the program due to a positive drug screen (n
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= 155), primarily tested positive for marijuana (69.03%), with cocaine (16.13%) and
methamphetamine (14.84%) being the next two most common substances identified;
23.23% tested positive for more than one substance.
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Table 1
Client Demographic Information
Full
sample
(N = 1,112)
Age M (SD, Range)

35.42 (10.22, 50)

Sex
Male n (%)

922 (82.9)

Female n (%)

99 (8.9)

Sex Unknown n (%)

91 (8.2)

Race/Ethnicity
African American n (%)

551 (49.6)

Euro-American n (%)

452 (40.6)

Latino(a)/Hispanic n (%)

12 (1.1)

Other Ethnicity n (%)

6 (0.5)

Unknown Race/Ethnicity n (%)

91 (8.2)

Employment Status
Employed n (%)

602 (54.1)

Unemployed n (%)

419 (37.7)

Employment Unknown n (%)

91 (8.2)

Marital Status
Unmarried n (%)

733 (65.9)

Married n (%)

132 (11.9)

Divorced n (%)

109 (9.8)

Separated n (%)

32 (2.9)

Widowed n (%)

12 (1.1)

Marital Status Unknown n (%)

94 (8.5)

Education (Highest Level Completed)
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Table 1 Continued
Some Grade School n (%)

454 (40.8)

High School/GED n (%)

399 (35.9)

Some Technical Education n (%)

11 (1.0)

Completed Technical Degree n (%)

2 (0.2)

Some College n (%)

83 (7.5)

Bachelor’s Degree n (%)

5 (0.4)

Education Unknown n (%)

158 (14.2)

Major Offense
Drug Related Offenses

389 (35.0)

Violent Offenses (not previously included)

168 (15.1)

Burglary Offenses

143 (12.9)

Theft Offenses

106 (9.5)

Weapons Offenses

62 (5.6)

Robbery Offenses

55 (4.9)

Interference/Obstruction/Fleeing Offenses

45 (4.0)

Fraud/Forgery/Financial Offenses

37 (3.3)

Other Offenses

12 (1.1)

Unknown Offense

95 (8.6)
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Measure
Outcome Rating Scale (ORS). The ORS (Miller & Duncan, 2000; see Appendix
A) is an ultra-brief self-report outcome measure that is to be administered to the client at
the beginning of each session in order to assess client progress throughout the course of
therapy. The client is asked to place a hash mark on each of four different ten-centimeter
visual analog lines to indicate her or his level of well-being or distress over the past week
on each domain. Marks to the left of the visual analog line indicate more distress or less
well-being on the particular domain, while marks to the right of the visual analog line
indicate less distress or more well-being on the domain. Three of the domains of client
functioning, which were derived from the OQ-45 (Lambert et al., 1996), include
“Individually” (the client’s view of her or his personal well-being or symptomatic
distress), “Interpersonally” (relational distress or the client’s satisfaction with close
relationships), and “Socially” (the client’s view of work/school and relationships outside
of the home). An “Overall” (general sense of well-being) scale was also included on the
ORS. The recorded distance for each of the four domains is then measured to the nearest
millimeter, totaled, and charted on a graph (see Appendix B). Total scores can range
from 0 to 40. Once the score has been totaled and recorded, the clinician can then discuss
the marks, as well as any changes in scores, with the client. The measure is available in
paper-and-pencil or electronic format, as well as in multiple languages.
In order to attribute increases in ORS scores over time to therapy, the difference
between any two measurements must exceed the reliable change index (RCI; Jacobson &
Truax, 1991). The RCI is a statistical formula that calculates the amount of change
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needed for results not to be attributable to chance or to the expected normal maturation of
the client. An analysis of over 400,000 administrations of the ORS determined the RCI
to be 6 points (Duncan, 2014). Utilizing a clinical sample (n = 435) and a nonclinical
community sample (n = 86), the clinical cutoff for the ORS was determined to be 25
(Miller, Duncan, Brown, Sparks, & Claud, 2003). Any score falling below the cutoff of
25 is indicative that the client has responded to the items in a manner that is similar to
other individuals seeking therapy (Miller & Duncan, 2004). Thus, in order to achieve
clinically significant change, a client must begin treatment with an ORS score of less than
25, improve by a minimum of six points, and complete treatment with an ORS score
equal to or greater than 25.
Empirical evidence for the reliability and validity of scores generated by the ORS
has been provided in four psychometric studies (Bringhurst, Watson, Miller, & Duncan,
2006; Campbell & Hemsley, 2009; Duncan, Sparks, Miller, Bohanske, & Claud, 2006;
Miller et al., 2003), in addition to the PCOMS manual (Duncan, 2011; Miller & Duncan,
2004). Across studies, Cronbach’s alpha (α) coefficients for ORS scores averaged .85 for
clinical samples and .95 for non-clinical samples (Gillaspy & Murphy, 2011). Three
studies (Bringhurst et al., 2006; Campbell & Hemsley, 2009; Miller et al., 2003) have
evaluated the concurrent validity of the ORS by comparing scores to the OQ-45 (Lambert
et al., 1996), a more established outcome assessment. The average bivariate correlation
between the scores was .62 (range .53 to .75), indicating moderately strong concurrent
validity (Gillaspy & Murphy, 2011). Additionally, ORS scores have been found to be
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sensitive to change for individuals in clinical samples, yet stable over time for those in
nonclinical samples (Bringhurst et al., 2006; Duncan et al., 2006; Miller et al., 2003).
Feasibility in clinical practice is also an important factor to examine when
considering the utility of a measure. The ORS was developed to address several concerns
with the OQ-45, including the length of time required to administer and score the
measure (Duncan, Miller, & Sparks, 2004). Miller, Duncan, Brown, Sparks, and Claud
(2003) evaluated the feasibility of the ORS by comparing clinicians’ compliance rates for
utilization of the ORS and the OQ-45 across two sites. After a period of 12 months, the
compliance rate for the OQ-45 was 25%, while that for the ORS was 89%.
For the present study, a modified scoring procedure was utilized for the ORS.
Treatment providers were trained and instructed to measure each visual analog line of the
scale to the nearest centimeter, as opposed to millimeter, which resulted in a whole
number score. The PCOMS trainer implemented this procedure for simplicity during
scoring and recording of the measures. One additional study has utilized a modified
administration and scoring of the measure (Miller et al., 2006). The authors evaluated the
use of PCOMS with a large sample (N = 6,424) of diverse clients who received treatment
via a telephonic-based employee assistance program (EAP). The ORS was administered
orally, as opposed to the typical paper/pencil or electronic formats, due to the nature of
the services being provided (i.e., telephonically). Clients were asked to orally provide a
rating from one to ten for each subscale of the ORS. Client outcomes were compared
between a FB condition and a benchmark TAU condition. Results revealed that effect
sizes for individual therapy doubled from the baseline period to the final evaluation
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period, increasing from d = 0.37 to d = 0.79 when PCOMS with a signal alarm system
was implemented. While information regarding the reliability of ORS scores for this
sample was not provided, an independent analysis of a sample of n = 15,778 from the
EAP produced a Cronbach’s alpha (α) coefficient of .79. Additionally, test-retest
reliability at the second administration of the ORS with a sample of n = 1,710 was .53.
Benchmarking Methodology
According to Minami, Serlin, et al. (2008), benchmarking allows for effectiveness
to be established by comparing whether the benefits obtained by clients in clinical
practice approach the benefits obtained by clients in controlled research studies. As
practice-based observational research does not generally allow for the comparison of
treatment groups to a control group, benchmarking techniques were developed to
compare routinely monitored outcomes from clinical settings with reliable outcome
standards observed in clinical trials. The most up-to-date benchmarking methodology,
which is increasingly being employed in effectiveness studies, was utilized in the present
study (see Minami et al., 2009; Minami, Wampold, et al., 2008; Minami et al., 2007;
Reese, Duncan, Bohanske, Owen, & Minami, 2014 for examples).
According to Minami, Serlin, et al. (2008), the three steps required in the
benchmarking methodology are as follows: (a) construct the pre-post treatment
benchmarks (i.e., ESs) from clinical trials, including benchmarks for wait-list controls or
TAU groups and for those who started but did not complete treatment (i.e., intent-totreat), (b) estimate the effectiveness of the sample being evaluated using pre-post effect
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sizes, and (c) statistically compare the ES estimates from the current sample (i.e.,
parolees referred to treatment) with those benchmarks established from the clinical trials.
Advancing on the existing benchmarking methodology, Minami, Serlin, et al.
(2008) included use of the “good-enough principle” (Serlin & Lapsley, 1985, 1993),
which allows for statistical testing with a range-null hypothesis, as opposed to a pointnull hypothesis, in order to prevent rejection due to a large N (i.e., Type I error). Because
increases in sample size can lead to increases in statistical power, using a point-null
hypothesis test could potentially result in any difference from 0 being found statistically
significant (Serlin & Lapsley, 1985, 1993). Thus, in order to appropriately and more
rigorously interpret comparisons, critical values will need to be calculated to statistically
determine whether the treatment ES estimate obtained from the naturalistic setting is
comparable to the efficacy benchmarks or greater than the waitlist control/TAU
benchmarks (Minami et al., 2007). Borrowing from previous benchmarking studies in
which a large sample was analyzed (Minami et al., 2009; Minami, Wampold, et al., 2008;
Reese et al., 2014), an a priori margin of difference of 10% was utilized. Any
differences between the naturalistic setting’s ESs and the respective benchmarks that are
within 10% of the benchmarks (90-110%) would be considered statistically trivial (i.e.,
fail to reject the null hypothesis) using a Type I error rate of α = .05.
As opposed to a traditional point-null hypothesis (e.g., H0 : δSURP = δITT, where
δSURP is the true ES of the Parolee Substance Use Recovery Program (SURP) and δITT
represents the true treatment efficacy benchmark from the intent-to-treat (ITT) samples of
the clinical trials), a range-null hypothesis (H0 : δSURP ≤ δITT – 10%) is used, which
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follows a non-central t-distribution (Serlin & Lapsley, 1985; 1993). Critical values were
calculated in order to statistically compare the ESs of the current Substance Use
Recovery Program sample to the computed clinical trial benchmark ESs. For example, a
critical value is calculated for the lower bound of the 90-110% range of the clinical trail
benchmark ES at dITT − 10%. Thus, the null hypothesis should not be rejected if the
difference is within 10%, while also maintaining an overall Type I error rate of α = .05.
Specifically, if the Substance Use Recovery Program ES falls at or above 90% of the
benchmark from clinical trials (i.e., benchmark minus 10%), the ES from the present
sample can be considered clinically equivalent to the clinical trial benchmark. For
comparison against the TAU benchmarks, if the Substance Use Recovery Program ES
falls within 110% of the TAU benchmarks (i.e., benchmark plus 10%), the Substance Use
Recovery Program ES will be considered clinically equivalent to TAU. In order to claim
the ES estimate was superior to TAU, the ES will need to exceed 110% of the TAU
benchmark, while also maintaining an overall Type I error rate of α = .05.
Construction of benchmarks. Pre-post benchmarks have been constructed from
as little as one RCT (e.g., Lee, Horvath, & Hunsley, 2013), two RCTs (e.g., Merrill,
Tolbert, & Wade, 2003; Wade et al., 1998), three RCTs (e.g., Curtis, Ronan, Heiblum,
and Crellin, 2009; Reese et al., 2014), or several RCTs (e.g., Weersing & Weisz, 2002).
Once selected for use in constructing the benchmark, clinical trials are combined using
standard meta-analytic procedures (e.g., Becker, 1988; Hedges and Olkin, 1985). Two
sets of benchmarks were constructed for the present study: (a) benchmarks from two
RCTs utilizing PCOMS in a group setting and (b) benchmarks from all six PCOMS
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RCTs (studies examining individuals, couples, and groups). Each set of benchmarks
includes an efficacy benchmark from the pre-post treatment outcomes of RCT FB
treatment groups, as well as a comparison benchmark from the pre-post scores of the
RCT TAU condition.
One primary consideration in the selection of clinical trials for inclusion in
constructing the benchmarks is the use of studies that employ comparable or equivalent
outcome measures. When selecting specific outcomes to aggregate among multiple
measures used in the studies, one must consider the matching of reactivity and specificity
both among and between the clinical trials. Because clinical trials may favor the use of
certain outcome measures that are not necessarily feasible to implement in naturalistic
settings, it becomes important to match the outcomes used for constructing the
benchmark and for assessing treatment effectiveness on these two criteria. Reactivity
primarily pertains to and is determined by who reported the outcomes; this may be a
clinician, the client, or an independent rater. Outcomes measured by the client will have
low reactivity, while those measured by an observer will have higher reactivity.
Specificity refers to the extent to which an outcome measure assesses symptoms specific
to a particular diagnosis as opposed to global functioning. Diagnosis-specific measures
are high in specificity, while measures of more broad symptoms of global distress are low
in specificity (Minami et al., 2007). The ORS, which is a self-report measure of overall
functioning and was the outcome measure utilized by the Parolee Substance Use
Recovery Program, is considered low in reactivity and low in specificity (LR-LS).
Constructing the feedback benchmarks from RCT studies that employed the ORS as the
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outcome measure and that utilized similar client feedback processes allowed for a more
direct comparison between the clinical trial data and the naturalistic setting data. Thus,
the use of PCOMS RCT studies helped to negate the concerns that can arise when
measures are not matched on reactivity and specificity.
Client feedback benchmarks. As there are at present no existing studies on the
use of continuous client feedback with offenders referred to treatment, the benchmarks
constructed for client feedback were derived from the best effort of equivalence. Given
this particular gap in the literature, client feedback benchmarks were constructed from the
existing RCTs utilizing PCOMS (Anker et al., 2009; Reese et al., 2009; Reese et al.,
2010; Schuman et al., 2015; Slone et al., 2015), as they permitted a direct comparison to
the outcome measure utilized in the present sample. As some of the aforementioned
studies were conducted with individuals (Reese et al., 2009) and couples (Anker et al,
2009; Reese et al., 2010), two separate sets of benchmarks were constructed for client
feedback. The first set of benchmarks contained only those studies using PCOMS in a
group setting (Schuman et al., 2015; Slone et al., 2015), while the second set of
benchmarks was constructed from all six existing RCT PCOMS studies. Each set of
benchmarks contained one for the FB conditions and one for the TAU conditions. Please
see Table 2 and Table 3 for the reported means and standard deviations of the studies that
were utilized in the construction of the PCOMS FB benchmarks and PCOMS TAU
benchmarks, respectively.
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Table 2
Studies Utilized for Construction of PCOMS FB Benchmarks
Study
Anker et al. (2009)

Type

N

Pretest

Post-test

M

SD

M

SD

d

Couple

206

18.08

7.85

26.35

10.02

1.05

Reese et al. (2009) 1

Individual

50

18.59

7.60

31.28

6.63

1.64

Reese et al. (2009) 2

Individual

45

18.68

10.39

29.51

9.58

1.02

Reese et al. (2010)

Couple

54

23.34

9.15

31.92

7.15

0.93

Schuman et al. (2015)*

Group

137

22.42

10.01

28.28

9.46

0.58

Slone et al. (2015)*

Group

43

23.47

7.86

30.87

6.49

0.43

Notes. FB = feedback; N = sample size; d = [1 - (3/4n - 5)] [Mpost - Mpre/SDpre]; M =
Mean; SD = Standard Deviation; ORS = Outcome Rating Scale; * = study utilized for
construction of PCOMS group setting benchmark.
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Table 3
Studies Utilized for Construction of PCOMS TAU Benchmarks
Study
Anker et al. (2009)

Type

N

Pretest

Post-test

M

SD

M

SD

d

Couple

204

18.58

7.03

21.69

8.69

0.44

Reese et al. (2009) 1

Individual

24

22.71

9.70

29.53

7.26

0.74

Reese et al. (2009) 2

Individual

29

19.64

6.46

24.33

7.51

0.70

Reese et al. (2010)

Couple

38

24.03

9.47

27.67

9.53

0.37

Schuman et al. (2015)*

Group

126

20.43

9.56

24.57

10.30

0.43

Slone et al. (2015)*

Group

41

22.02

7.06

27.26

6.85

0.73

Notes. TAU = treatment as usual; N = sample size; d = [1 - (3/4n - 5)] [Mpost Mpre/SDpre]; M = Mean; SD = Standard Deviation; ORS = Outcome Rating Scale; * =
study utilized for construction of PCOMS group setting benchmark.
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Offender treatment benchmarks. A systematic search of the literature was
conducted utilizing the Academic Search Complete, MEDLINE, Psychology and
Behavioral Sciences Collection, PsycINFO, and Sociological Collection databases.
Keywords utilized in the search included group psychotherapy, group therapy, group
counseling, inmate, offender, prison, prisoner, parole, parolee, substance use, substance
use disorder, and substance abuse. Results were limited to scholarly/peer-reviewed
articles published since 2000. The aforementioned search parameters resulted in 84
distinct articles. Studies were excluded if they did not use a RCT design, did not employ
a comparable outcome measure (LR-LS) assessing global functioning, did not focus on
outpatient group substance abuse treatment for adults, and did not provide means and
standard deviations for the entire (i.e., ITT) sample in order to calculate ESs.
Additionally, studies were excluded if they focused on adolescents or female offenders
only, as the present sample was primarily composed of adult males, or if they focused on
a specific type of offense (e.g., sex offenses, domestic violence offenses). The systematic
search of the extant clinical trial literature did not result in any RCT studies that met
criteria for inclusion in construction of the offender substance abuse treatment
benchmark.
The literature search did result in one meta-analytic synthesis of research on the
effect of incarceration-based drug treatment on recidivism (Mitchell, Wilson, &
MacKenzie, 2007). The reference list of this article was examined for any additional
studies that could potentially meet inclusion criteria; no studies were found. One
additional meta-analysis was found that examined the effects of CBT therapy for
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substance abuse (Magill & Ray, 2008). This analysis was examined for possible
inclusion; however, outcomes utilized were related to substance use reduction (e.g., days
abstinent, rate abstinent, days used), not general well-being. Additionally, Taxman’s
(2011) chapter from Leukefeld, Gullotta, and Gregrich’s (2011) text on evidence-based
substance abuse treatment in criminal justice settings was examined for potential studies
for inclusion that focus on parole samples. Of the studies noted in the overview of
existing literature for parolee substance abuse treatment, only one (Burke, Arkowitz, &
Menchola, 2003) noted outcomes other than substance use, crime reduction, treatment
utilization, or treatment retention. As such, Burke, Arkowitz, and Menchola’s (2003)
meta-analysis was examined for possible inclusion as a comparison benchmark.
However, the study only included clinical trials of therapy delivered in an individual, as
opposed to group, format.
Based on the paucity of research meeting the aforementioned inclusion criteria,
the literature search was modified to include general group therapy for offenders, as
opposed to specifically substance abuse group treatment. A systematic search of the
literature was conducted using the aforementioned databases and the following keywords:
group counseling, group therapy, group psychotherapy, offender, parole, inmate,
prisoner, well-being, outcome, and efficacy. The aforementioned search parameters
resulted in 142 distinct articles. Similar exclusion criteria were employed, with the
exception of a focus on substance abuse treatment. The systematic literature search again
resulted in zero RCT studies for use in construction of the offender treatment benchmark.
However, the search did result in two systematic reviews of group treatment for

55

offenders; these articles were examined for studies meeting inclusion criteria. The
reviews conducted by Morgan and Flora (2002) and Duncan, Nicol, Ager, and Dalgleish
(2006) were examined, as were the reference lists from the articles. The reviews did not
include only RCT studies; the RCT studies that were included in the analyses were
examined for possible use in construction of a benchmark. However, no comparable
RCT studies were found.
Client feedback benchmark effect size calculations. After the selection of RCT
studies for inclusion, the following client feedback benchmarks were calculated: (a) FB
ITT samples from two PCOMS group studies, (b) TAU from two PCOMS group studies,
(c) FB ITT from all six PCOMS studies, and (d) TAU from all six PCOMS studies.
Following the guidelines of Minami, Serlin, et al. (2008), for each clinical trial i, the
unbiased pre-post Cohen’s d ES estimate was calculated using the formula

"
3 % M i, post − M i, pre
di = $1−
'
SDi, pre
# 4n i− 5 &
where ni is the sample size, Mi, post is the post-treatment mean of the measure, Mi, pre is the
pretreatment mean of the measure, and SDi, pre is the pretreatment standard deviation.
Following the calculation of individual ES estimates di for each study, they were
aggregated across clinical trials to produce a single ES value that served as the
benchmark. ES estimates were aggregated using the meta-analytic formula and
guidelines specified in Minami, Serlin, et al. (2008). Specifically, the variance of each
RCT di is estimated by the formula
𝜎!! ! =   

!(!!  !! )
!!

!!

+ !!!

!
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where ni is the sample size, di is the ES estimate, and ri is the estimated correlation
between the pretreatment and post-treatment scores of the outcome measure (Becker,
1988).
After the ESs di are calculated for each study, they are aggregated into a single
value which will serve as the benchmark ES using the formula

dB = ∑
i

di
^ 2

σ d (i)

∑
i

1
^ 2

σ d (i) ,

where the value of dB is considered fixed. Four feedback benchmarks were constructed:
Aggregated treatment ES were calculated for the FB (dFBgrp = 0.65) and TAU (dTAUgrp =
0.50) samples from the two PCOMS group RCTs and for the FB (dFBall = 0.91) and TAU
(dTAUall = 0.48) samples from all six PCOMS RCTs. Please see Table 4 for the client
feedback effect size comparisons.
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Table 4
Effect Size Comparisons for Client Feedback Studies
Study

N

d

95% CI

1,112

0.59

[0.52, 0.66]

PCOMS group studies

180

0.65

[0.46, 0.84]

All PCOMS studies

535

0.92

[.80, 1.04]

Current Study

Notes. Six total studies were evaluated for comparison; two evaluated group treatment.
PCOMS = Partners for Change Outcome Management System; N = sample size; d = [1 (3/4n - 5)] [Mpost - Mpre/SDpre]; M = Mean; CI = confidence interval.
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Critical value calculation. Because increases in sample size can lead to increases
in statistical power, using a point-null hypothesis test could potentially result in any
difference from zero being found statistically significant (Serlin & Lapsley, 1985, 1993).
Thus, in order to appropriately interpret comparisons using a range-null hypothesis while
maintaining an overall Type I error rate of α = .05, critical values were calculated.
Following Minami, Serlin, et al. (2008), the benchmarking hypotheses rely on a 95th
percentile test statistic (e.g., t(FB) ν,λ:.95 and t(TAU) ν,λ:.95), which follows a non-central t
distribution with v = N – 1 degrees of freedom and a noncentrality parameter 𝜆 =  
√N(dFB – 10% ) or 𝜆 =  √N(dTAU + 10%). The critical values for the feedback-related
benchmarks were determined by a normal approximation of the distribution and resulted
in (dcv(FBgrp) = 0.64) and (dcv(TAUgrp) = 0.60) for only the PCOMS group studies and
(dcv(FBall) = 0.89) and (dcv(TAUall) = 0.58) for all PCOMS studies. In other words, the
critical values for the FB condition ESs are based on the lower bound of the 10 percent
range of clinical equivalence, while the critical values for the TAU condition ES are
based on the upper bound of the 10 percent range of clinical equivalence.
Data Analysis
Means, standard deviations, and ESs were calculated for the full sample by study
sample characteristics, including sex and ethnicity (see Table 5).
Effect size calculation. The pre-post ES (Cohen’s d) was calculated for the full
sample using baseline (i.e., MAP score), endpoint (last observation), and standard
deviation from client ORS scores. Consistent with the ES calculation for clinical trials
that was previously noted, the formula
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"
3 % M i, post − M i, pre
di = $1−
'
SDi, pre
# 4n i− 5 &
was used to calculate the unbiased ES estimates for the full Substance Use Recovery
Program sample, where n is the sample size, M is the mean of the measure, and SD is the
standard deviation. The calculation of the ES for the naturalistic setting sample allowed
for comparison to the published efficacy studies in the benchmark ESs. The variance of
the current sample was also estimated and reported using
!
𝜎!(!)
=   
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where ri is the estimated correlation between the pre- and post-treatment scores of the
outcome measure (Becker, 1988). The Pearson product-moment correlation coefficient
for the present sample was calculated (r = 0.278). As noted in Minami, Serlin, et al.
(2008), the value utilized in the aggregation of effect sizes would also be utilized in the
calculation of the variance of the current sample.
Benchmarking analyses. Lastly, benchmarking analyses were conducted. As
previously mentioned, range-null hypotheses were utilized to compare the ES from the
present sample (i.e., the Parolee Substance Use Recovery sample) to the selected clinical
trial benchmarks. Range-null hypotheses were utilized, as the use of point-null would
have likely led to the false rejection of the hypotheses due to large sample sizes (i.e.,
Type I error). As increases in sample size can lead to increases in statistical power, the
use of a point-null hypothesis could potentially result in any difference from zero being
found statistically significant (Serlin & Lapsley, 1985, 1993). Thus, range-null
hypotheses with an a priori 10% margin of difference were utilized to more rigorously
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compare the Substance Use Recovery Program sample with the established benchmarks.
The range-null hypothesis follows a non-central t statistic (Serlin & Lapsley, 1985, 1993)
and a normal distribution in approximated. Critical values associated with each
benchmark, which represented the 95th percentile value of the non-central t-distribution,
were calculated and employed (see detailed description above) in order to compare ESs.
Clinical significance testing using the 10% margin of difference that surrounds the
efficacy trial benchmarks and statistical testing that maintained an overall Type I error
rate of α = .05 allowed for appropriate evaluation and comparison of the effectiveness of
the Substance Abuse Recovery Program with established clinical trials.
Benchmarking against client feedback conditions. In order for the Substance
Use Recovery Program sample ES to be considered clinically equivalent to the ITT
feedback efficacy benchmark for the PCOMS group studies dCV(FBgrp), the present sample
ES needs to exceed the critical value
dCV(FBgrp) =

!!,!:!"
!

,

where 𝑡!,!:!"   is the 95th percentile value of the non-central t distribution and 𝜆 =
  √𝑁(𝑑!"(!"#$%) − 10%  ) is the noncentrality parameter. Similarly, in order for the
Substance Use Recovery Program sample ES to be considered clinically equivalent to
ITT feedback efficacy benchmark for all PCOMS studies dCV(FBall), the present sample ES
needs to exceed the critical value
dCV(FBall) =

!!,!:!"
!

,
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where 𝑡!,!:!"   is the 95th percentile value of the non-central t distribution and 𝜆 =
  √𝑁(𝑑!"(!"#$$) − 10%  ) is the noncentrality parameter.
Benchmarking against treatment-as-usual conditions. Significance testing for
comparison of the Substance Use Recovery Program ESs to the TAU conditions efficacy
trial ESs is similar to the procedures outlined above; however, in regards to the noncentrality parameter, -10% in the formula is replaced with +10%. As such, the Substance
Use Recovery Program sample ES estimate is considered statistically and clinically
equivalent to a TAU condition in client feedback efficacy trials if it does not statistically
significantly exceed the TAU benchmark at the 10 percent critical value. Comparisons
were made to the TAU conditions from only the group PCOMS studies and the TAU
conditions from all PCOMS studies.
Research Hypotheses
There are four primary hypotheses for the present study. For the first two, it was
hypothesized that the treatment outcomes for the Substance Use Recovery Program
would be (a) clinically equivalent to efficacy outcomes observed in the feedback
treatment conditions of the group only PCOMS studies and (b) clinically equivalent to
the efficacy outcomes observed in the feedback treatment conditions of all PCOMS
studies. For the second two, it was hypothesized that the treatment outcomes for the
current sample would be (a) clinically superior to the efficacy outcome observed in the
TAU conditions of the group only PCOMS studies and (b) clinically superior to the
efficacy outcomes observed in the TAU conditions of all PCOMS studies.

62

Hypothesis one. Utilizing range-null hypothesis testing guidelines from Serlin
and Lapsley (1985, 1993) that were illustrated in Minami, Serlin, et al. (2008), when
δ!"#$ is the true population ES estimate of the Substance Use Recovery Program (SURP)
full sample (in Cohen’s d), δFBgrp is the true population client feedback efficacy
benchmark from the PCOMS group studies (in Cohen’s d), and 10% is the maximum
difference allowed to claim clinical equivalence, the range null and alternative
hypotheses are:
H0 : δSURP ≤ δFBgrp – 10%
H1 : δSURP > δFBgrp – 10%.
Hypothesis two. Similar to hypothesis one, utilizing the guidelines for range-null
hypothesis testing that were outlined by Serlin and Lapsley (1985, 1993) and illustrated
by Minami, Serlin, et al. (2008), when δ!"#$ is the true population ES of the present full
sample (in Cohen’s d), δFBall is the true population client feedback efficacy benchmark
from all PCOMS studies (in Cohen’s d), and 10% is the maximum difference allowed to
claim clinical equivalence, the range-null and alternative hypotheses are:
H0 : δSURP ≤ δFBall – 10%
H1 : δSURP > δFBall – 10%.
Hypothesis three. The Substance Use Recovery Program ES estimate will be
considered statistically and clinically superior to the TAU conditions in group client
feedback efficacy trials if it statistically significantly exceeds the TAU benchmark at the
10 percent critical value (i.e., exceeds the TAU comparison benchmark by 110%). When
δ!"#$ is the true population ES estimate (in Cohen’s d) of the Substance Use Recovery

63

Program sample, δTAUgrp is the true population ES estimate (in Cohen’s d) of the TAU
efficacy benchmark from the PCOMS group studies, and 10% is the maximum difference
allowed to claim equivalence, the range-null and alternative hypotheses are:
H0 : δSURP ≤ δTAUgrp + 10%
H1 : δSURP > δTAUgrp + 10%.
Hypothesis four. Similar to hypothesis three, if the Substance Use Recovery
Program ES estimate exceeds the TAU comparison benchmark from all PCOMS studies
by 110%, it will be deemed clinically superior to the established TAU benchmark. Thus,
when δ!"#$ is the true population ES estimate (in Cohen’s d) of the Substance Use
Recovery Program sample, δTAUall is the true population ES estimate (in Cohen’s d) of the
TAU efficacy benchmark from all PCOMS studies, and 10% is the maximum difference
allowed to claim equivalence, the range-null and alternative hypotheses are:
H0 : δSURP ≤ δTAUall + 10%
H1 : δSURP > δTAUall + 10%.
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Chapter Three: Results
Preliminary Analyses
The original data set (N = 3,250) contained 269 cases in which an initial
Motivation Assessment and Planning (MAP) score was not provided, but a Recovery
Action and Progress (RAP) session one score was recorded. An independent samples ttest was conducted to determine whether a statistically significant difference existed
between the ORS pretest score for those individuals with a MAP score at pretest (n =
1,112) and those individuals with a RAP session one score at pretest (n = 269). Type of
pretest score was the independent variable and initial ORS score was the dependent
variable. Results indicate a statistically significant difference in mean ORS pretest scores
for those with a RAP session one score at pretest (M = 33.02, SD = 6.67) as compared to
those with a MAP score at pretest (M = 31.26, SD = 6.68), t(1379) = 3.89, p < .001, d =
0.26. Similar results were obtained when the ORS pre-post change score was used as the
dependent variable and type of pre-test score was used as the independent variable.
Results of the independent samples t-test revealed a statistically significant difference in
mean ORS change (pre-post) scores for those with a RAP session one score at pretest (M
= 1.23, SD = 6.93) and those with a MAP score at pretest (M = 3.93, SD = 7.34), t(1379)
= -5.46, d = 0.37. As such, individuals without a MAP score but with a RAP session one
pretest score were excluded from analyses.
Average session numbers were calculated for the remaining sample. The average
number of sessions for the full Substance Use Recovery Program sample (n= 1,112) was
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5.39, SD = 2.00. Please see Table 5 for therapy outcomes by client demographic
characteristics.
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Table 5
Therapy Outcomes by Client Demographics
Sample
Size
99

ORS Pre
M (SD)
31.58 (7.07)

ORS Post
M (SD)
35.72 (5.17)

Within Group
d (95% CI)
0.58 [0.35, 0.81]

Male

922

31.22 (6.66)

35.21 (5.30)

0.60 [0.52, 0.68]

African American

551

30.38 (7.18)

34.68 (5.58)

0.60 [0.49, 0.71]

Latino(a)/Hispanic
Euro-American

12
452

32.92 (6.69)
32.20 (5.89)

36.58 (3.12)
35.94 (4.85)

0.51 [-0.16, 1.18]
0.63 [0.51, 0.75]

Other Ethnicity

6

36.17 (6.21)

33.67 (7.55)

0.34 [-.020, 0.88]

Female

Notes. N = 1,021; sex and ethnicity were not provided for 91 clients. d = [1 - (3/4n - 5)]
[Mpost - Mpre/SDpre]. ORS = Outcome Rating Scale; CI = confidence interval.
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A multiple linear regression analysis was conducted in order to examine the
predictive ability of demographic variables (i.e., age, sex, race/ethnicity, education level,
employment, and marital status) and overall offense type on ORS pre-post change scores.
Prior to analysis, all categorical variables with more than two values were dummy coded.
The full model had an R2 = .020, F(23, 997) = .90, p = .61. None of the selected variables
statistically significantly predicted ORS pre-post change score. Please see Table 6 for the
correlations of each demographic variable with ORS pre-post change score and the
regression weights. Structure coefficients, or the correlations of the particular variable
with the predicted score in the model, are also displayed in Table 6.
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Table 6
Correlations and Results from Multiple Regression Model
𝛽

rst

Age

Correlation
with ORS
Change
-.013

-.043

-.09

Sexa

.006

.002

.04

Variable

Race/Ethnicity
Euro-American

-.021

Reference Category

African American

.051

.055

.31

Latino(a)/Hispanic

-.004

-.004

-.04

Other

-.065*

-.059

-.49

Education Level
High School/GED

.052

Reference Category

Some Grade School

-.010

-.039

-.15

Some Technical Education

.017

.010

.12

Completed Technical Education

-.011

-.020

-.08

Some College

-.034

-.045

-.27

Bachelor’s Degree

.004

-.001

.03

Marital Status
Married

.045

Unmarried

-.019

-.083

-.28

Separated

-.015

-.037

-.13

Divorced

.015

-.015

.08

Widowed

.030

.027

.21

-.023

-.018

-.16

Employmentb

Reference Category

Major Offense
Drug Related Offenses

.006
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Reference Category

Table 6 Continued
Violent Offenses (not previously included)

.025

.018

.15

Burglary Offenses

.011

.015

.05

Theft Offenses

-.009

-.011

-.10

Weapons Offenses

-.039

-.047

-.32

Robbery Offenses

-.015

-.025

-.13

Interference/Obstruction/Fleeing Offenses

.030

.023

.20

Fraud/Forgery/Financial Offenses

.001

-.002

-.01

Other Offenses

.033

.036

.24

Notes. ORS = Outcome Rating Scale. rst = structure coefficient.
a
0 = male, 1 = female. b 0 = not employed, 1 = employed.
* p < .05
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Results of Client Feedback Benchmark Hypotheses
The following results are based on the full Parolee Substance Use Recovery
Program sample. The mean pretreatment and post-treatment ORS scores for the full
sample (N = 1,112) were Mpre = 31.26 (SD = 6.68) and Mpost = 35.18 (SD = 5.42),
respectively, producing an observed standardized pre-post mean change of dSURP = 0.59
(see Table 7) with a variance of .001. As previously reported, all analyses utilized critical
values with a Type I error rate of α = 0.05.
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Table 7
Critical Value Comparisons for Client Feedback Benchmarks
Feedback
Benchmark
(group
PCOMS)
SURP d

dcv

p

TAU
Benchmark
(group
PCOMS)
dcv
p

Feedback
Benchmark
(all
PCOMS)
dcv
p

TAU
Benchmark
(all
PCOMS)
dcv
p

0.59
0.64
.441
0.60
.110
0.89
.999 0.58
.028
Notes. SURP = Substance Use Recovery Program; PCOMS = Partners for Change
Outcome Management System; TAU = treatment as usual; d = [1 - (3/4n - 5)] [Mpost Mpre/SDpre]; dcv = critical effect size value required to attain statistical significance.
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Hypothesis one. The first specified hypothesis was that the ES estimate for the
full Substance Use Recovery Program sample (dSURP = 0.59; N = 1,112) would be
statistically and clinically equivalent to efficacy outcomes observed in the FB treatment
conditions of the group only PCOMS studies. Compared against the group only PCOMS
FB benchmark (dFBgrp = 0.65) with a 10% a priori margin (dFBgrp[90%] = 0.59) and a
critical value dCV(FBgrp) = 0.64, the observed Substance Use Recovery Program effect size
estimate was not considered clinically equivalent (t = 19.67, df = 1,111, 𝜆 = 19.51, p =
.44) to the FB treatment outcomes from the two group only PCOMS studies. The
estimated effect of the Substance Use Recovery Program sample did not exceed the
magnitude of effect deemed necessary in order to claim at least clinical and statistical
equivalence with the FB treatment outcomes from the two group PCOMS RCTs.
Hypothesis two. The second hypothesis was that the ES estimate for the full
Substance Use Recovery Program sample (dSURP = 0.59; N = 1,112) would be statistically
and clinically equivalent to efficacy outcomes observed in the FB treatment conditions of
all PCOMS studies. Compared against the constructed benchmark for the FB conditions
of all PCOMS studies (dFBall = 0.92) with a 10% a priori margin (dFBgrp[90%] = 0.83) and
a critical value dCV(FBgrp) = 0.89, the observed Substance Use Recovery Program effect
size estimate was not considered clinically equivalent (t = 19.67, df = 1,111, 𝜆 = 27.61, p
= .999) to the established benchmark. In other words, the estimated effect of the
Substance Use Recovery Program sample did not exceed the established critical value
(dCV(FBgrp) = 0.88) necessary in order to claim at least clinical and statistical equivalence
with the FB treatment outcomes from all PCOMS RCTs.
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Hypothesis three. The third hypothesis posited the ES estimate for the full
Substance Use Recovery Program sample (dSURP = 0.59; N = 1,112) would be clinically
and statistically superior to the constructed TAU benchmark from the two PCOMS group
clinical trials. Compared against the TAU benchmark from the PCOMS group studies
(dTAUgrp = 0.50), given a 10% a priori margin of difference (dTAUgrp [110%] = 0.55) and a
critical value dCV(TAUgrp) = 0.60, the observed Substance Use Recovery Program ES
estimate was not considered clinically superior (t = 19.67, df = 1,111, 𝜆 = 18.34, p =
.110). In other words, the estimated effect of the Substance Use Recovery Program
sample did not exceed the established magnitude of effect necessary in order to claim
clinical superiority to TAU from the two PCOMS group studies.
Hypothesis four. The fourth hypothesis specified that the ES estimate for the full
Substance Use Recovery Program sample (dSURP = 0.59; N = 1,112) would be clinically
superior to the TAU benchmark constructed from all of the PCOMS RCTs. Compared
against the TAU benchmark (dTAUall = 0.48), given a 10% a priori margin of difference
(dTAUgrp [110%] = 0.53) and a critical value dCV(TAUgrp) = 0.58, the observed Substance
Use Recovery Program ES estimate was statistically significant (t = 19.67, df = 1,111, 𝜆
= 17.61, p < .001), suggesting that treatment provided via the Substance Use Recovery
Program was clinically superior to the TAU group outcomes from all PCOMS RCTs.
Supplemental Analyses
Several supplemental analyses were conducted in order to gain a better
understanding of the effectiveness of the Parolee Substance Use Recovery Program. The
results of the secondary analyses are discussed below.
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Clinical significance. As was previously reviewed, the ORS was determined to
have a reliable change index (RCI) of six points or more and a clinical cutoff score of 25
for adults aged 18 years and over (Duncan, 2014). Thus, by combining the RCI and the
clinical cutoff score, one is able to examine the rates of reliable and clinically significant
change. An individual is considered to have obtained reliable change if the pre-post ORS
change score was at least six points. Furthermore, an individual is considered to have
achieved clinically significant change if the initial ORS score below was below 25, there
was a pre-post ORS change score of at least six points, and the post ORS score was at
least 25. Examining the rates of reliable and clinically significant change is another
means by which to examine and understand clinical effectiveness. For the full Substance
Use Recovery Program sample, the rate of reliable change was 37.77% (n = 420) and the
rate of clinically significant change was 11.60% (n = 129). Additionally, 6.92% (n = 77)
of the full sample reliably deteriorated during treatment, meaning there was a decrease of
at least six points from the baseline measure. Of those who experienced deterioration,
22.08% (n = 17) attended only two treatment sessions.
Clinical cutoff analysis. A supplemental analysis was conducted to examine the
effectiveness of treatment for individuals (n = 170) who had an initial ORS score below
the clinical cutoff of 25. According to Miller and Duncan (2004), individuals with a
score that falls below this cutoff have responded to the items in a manner that is similar to
other individuals seeking therapy. The mean pretreatment and post-treatment ORS scores
for the clinical cutoff sample were Mpre = 19.44 (SD = 4.49) and Mpost = 31.98 (SD =
6.95), respectively, producing an observed standardized pre-post mean change of dcutoff =
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2.79 with a variance of .033. All analyses utilized critical values with a Type I error rate
of α = 0.05. Table 8 presents a comparison of the ES critical value for the clinical cutoff
sample with the ES critical values observed in PCOMS studies.
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Table 8
Critical Value Comparisons for Clinical Cutoff Sample
Feedback Benchmark
(group
PCOMS)
SURP d

dcv

p

Feedback Benchmark
(all
PCOMS)
dcv

p

2.79
0.73
<.001
0.98
<.001
Notes. SURP = Substance Use Recovery Program; PCOMS = Partners for Change
Outcome Management System; d = [1 - (3/4n - 5)] [Mpost - Mpre/SDpre]; dcv = critical
effect size value required to attain statistical significance.
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When the ES for individuals falling below the clinical cutoff (dcutoff = 2.79) was
compared against the group only PCOMS FB benchmark (dFBgrp = 0.65) with a 10% a
priori margin (dFBgrp[90%] = 0.59) and a critical value dCV(FBgrp) = 0.73, the observed
Substance Use Recovery Program ES estimate for those who began treatment below the
clinical cutoff was considered clinically equivalent (t = 36.38, df = 169, 𝜆 = 7.63, p <
.001) to the FB treatment outcomes from the two group only PCOMS studies. The
estimated effect of the Substance Use Recovery Program sample exceeded the magnitude
of effect deemed necessary in order to claim at least clinical and statistical equivalence
with the FB treatment outcomes from the two group PCOMS RCTs.
Similar results were obtained when the ES for individuals falling below the
clinical cutoff at the start of therapy was compared to the FB benchmark from all
PCOMS studies (dFBall = 0.92). With a 10% a priori margin (dFBgrp[90%] = 0.83) and a
critical value dCV(FBgrp) = 0.98, the observed Substance Use Recovery Program effect size
estimate was considered clinically equivalent (t = 36.38, df = 169, 𝜆 = 10.80, p < .001) to
the established benchmark. In other words, the estimated effect of the Substance Use
Recovery Program clinical cutoff sample exceeded the established critical value
(dCV(FBgrp) = 0.98) necessary in order to claim at least clinical and statistical equivalence
with the FB treatment outcomes from all PCOMS RCTs.
Analysis of treatment completers. A similar supplemental analysis was
conducted for those individuals (n = 544) who successfully completed the Substance Use
Recovery Program treatment by attending at least six consecutive therapy sessions and
obtaining at least two negative drug screens. The mean pretreatment and post-treatment
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ORS scores for the treatment completer sample were Mpre = 31.71 (SD = 6.54) and Mpost =
36.84 (SD = 4.07), respectively, producing an observed standardized pre-post mean
change of dcompleter = 0.78 with a variance of .003. All analyses utilized critical values
with a Type I error rate of α = 0.05. Please see Table 9 for a comparison of the ES
critical value for the sample of those who successfully completed treatment with the ES
critical values observed in PCOMS studies.
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Table 9
Critical Value Comparisons for Completer Sample
Feedback Benchmark
(group
PCOMS)
SURP d

dcv

p

Feedback Benchmark
(all
PCOMS)
dcv

p

0.78
0.66
.02
0.91
0.83
Notes. SURP = Substance Use Recovery Program; PCOMS = Partners for Change
Outcome Management System; d = [1 - (3/4n - 5)] [Mpost - Mpre/SDpre]; dcv = critical
effect size value required to attain statistical significance.
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When the ES for individuals who successfully completed treatment (dcompleter =
0.78) was compared against the group only PCOMS FB benchmark (dFBgrp = 0.65) with a
10% a priori margin (dFBgrp[90%] = 0.59) and a critical value dCV(FBgrp) = 0.66, the
observed Substance Use Recovery Program ES estimate for those who completed
treatment was considered clinically equivalent (t = 18.19, df = 543, 𝜆 = 13.64, p = 0.02)
to the FB treatment outcomes from the two group only PCOMS studies. The estimated
effect of the Substance Use Recovery Program sample exceeded the magnitude of effect
deemed necessary in order to claim at least clinical and statistical equivalence with the
FB treatment outcomes from the two group PCOMS RCTs.
An analysis was also conducted to compare the ES from those who successfully
completed treatment to the FB benchmark from all PCOMS studies (dFBall = 0.92). With
a 10% a priori margin (dFBgrp[90%] = 0.83) and a critical value dCV(FBgrp) = 0.91, the
observed Substance Use Recovery Program effect size estimate was not considered
clinically equivalent (t = 18.19, df = 543, 𝜆  =  19.31,  p  =  0.84)  to the established
benchmark. In other words, the estimated effect of the Substance Use Recovery Program
completer sample did not exceed the established critical value (dCV(FBgrp) = 0.91)
necessary in order to claim at least clinical and statistical equivalence with the FB
treatment outcomes from all PCOMS RCTs.
Substance use outcomes. In regards to substance use outcomes, 48.92% (n =
544) of the present sample successfully completed treatment, which included obtaining at
least two negative drug screens. However, 13.94% (n = 155) of the full sample had to
restart the Parolee Substance Use Recovery Program due to obtaining a positive drug
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screen. A meta-analysis of comparison group studies examining the effectiveness of
substance abuse treatment conducted by Prendergast, Podus, Chang, and Urada (2002)
was utilized to compare substance use outcomes. The meta-analysis was conducted on
78 treatment-comparison group studies conducted between 1965 and 1996 that examined
either treatment programs or techniques for substance abuse. In order to be included in
the analysis, studies had to include at least one crime or substance use outcome variable.
Crime use was primarily measured via self-report; however, criminal records were less
frequently available. Substance use was measured via self-report, drug testing, or a
combination of both. Nearly 80% of the studies included in the analysis utilized an active
comparison group (i.e., routine treatment, placebo treatment, or alternative treatment)
while the remainder utilized a passive comparison group (i.e., no treatment, minimal
treatment, or delayed/wait-list).
Authors of the meta-analysis utilized the binomial ES display (BESD) as
developed by Rosenthal and Rubin (1979, 1982) to transform the observed treatment ES
regarding substance use into a percentage. The BESD is defined as the percentage of
study participants in the treatment and comparison groups who achieve a common
success criterion; this is arbitrarily defined as the median of the scores of the combined
groups. It is noted that the overall median should be regarded as a hypothetical
representation of success rates as criteria for success of treatment is often not available or
easily defined. Results of the BESD indicated a 57% success rate for treatment groups
and a 42% success rate for comparison groups in regards to drug use outcomes.
Descriptively, the rate of successful completion for the present sample (which includes
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obtaining two negative drug screens) was higher than the drug use outcome for
comparison groups, but lower than that observed in the treatment groups. Please see
Figure 1 for a comparison of the substance use success rates for the present sample and
the Prendergast et al. (2002) meta-analysis.
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Figure 1. Comparison of substance use success rates. SURP = Substance Use Recovery
Program.
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Chapter Four: Discussion
At present, studies examining the effectiveness of group therapy for offenders
have yielded mixed and inconsistent results (Morgan & Flora, 2002). Additionally,
evidence for the efficacy of continuous client feedback within group psychotherapy
settings is emerging. Furthermore, a thorough search of the literature failed to find any
studies that have evaluated the use of a continuous client feedback system with offenders
referred to attend group treatment. The present study, to the best of my knowledge,
presents the first benchmarking analysis of treatment outcomes for offenders referred to
treatment who utilized a continuous client feedback system as a quality improvement
strategy. The benchmarking analyses confirmed one of the four hypotheses. Results
revealed the magnitude of change observed in the Substance Use Recovery Program
sample was not clinically equivalent to the FB benchmark constructed from the two
PCOMS group RCTs (Hypothesis 1) or to the FB benchmark constructed from all six
PCOMS RCTs (Hypothesis 2). Additionally, the ES estimate for the Substance Use
Recovery Program sample was not determined to be clinically superior to the TAU
benchmark constructed from only the two PCOMS group studies (Hypothesis 3).
However, it was determined that the magnitude of change in treatment outcomes
observed in the Substance Use Recovery Program sample was clinically superior to the
TAU benchmark constructed from all six PCOMS RCT studies, which included the two
PCOMS group studies (Hypothesis 4).
Additionally, preliminary analyses were conducted on the client demographic
variables of sex category and race/ethnicity. Treatment outcomes as measured by the
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pre-post change score were not found to statistically significantly differ based on the
aforementioned demographic variables. However, it should be noted that sex and
race/ethnicity data was missing for 8.2% of the present sample.
Effectiveness of Client Feedback with Offenders Referred to Treatment
Results of the present study examining the effectiveness of continuous
client feedback for offenders referred to treatment were not clinically equivalent to the
benchmarks constructed from the FB conditions of RCT studies. The use of client
feedback with this particular sample did not produce treatment outcomes similar to those
observed in rigorous RCTs. This was similar to the results obtained in Reese et al.’s
(2014) benchmarking study in which the total sample ES estimate was found to be not
comparable to the RCTs of PCOMS alone; ES estimates were, however, comparable to
RCTS of the OQ System and PCOMS combined. While the observed ES estimate for the
present full sample was not found to be equivalent to RCTs of PCOMS, it is worth noting
that the confidence interval for the ES of the full Substance Use Recovery Program
sample overlapped with the confidence interval for the ES of the FB condition of the
group PCOMS studies.
One factor to note in regards to the benchmarking methodology is the use of an a
priori margin of difference of 10%. This particular margin was selected for use in the
present study based on previous research utilizing benchmarking methodology. While
the use of a margin of 10% provides a rigorous standard for statistically comparing the
ES from the naturalistic setting sample with constructed benchmarks from RCTs, it is
noted that 10% may be objectionable as criteria for establishing comparability to FB
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conditions and superiority to TAU conditions. It, perhaps, provides an unfair criterion for
comparison. Minami, Wampold, et al. (2008) note that such a criticism “cannot be
refuted unless the field reaches a consensus on an effect size that would constitute
comparability (similar to the adoption of α = 0.05 as the criterion for Type I effort rate)
(p. 122).”
Several particular characteristics of the offender population are worthy of noting
when considering the results regarding client feedback. It is important to acknowledge
that the mean ORS pretest score (M = 31.26) for the full sample was well above the
clinical cutoff score for the measure; a factor that is common for mandated clients,
according to Miller, Mee-Lee, Plum, and Hubble (2005). In contrast, for each of the six
PCOMS studies utilized for the construction of the benchmarks, the mean ORS pretest
score for the full sample fell below the clinical cutoff of 25. In fact, the mean ORS
pretest score for the present sample was larger than the average of the mean ORS posttest scores from the FB conditions of all PCOMS RCT studies (M = 29.70). When
examining only those individuals who started treatment with a pre-test ORS score below
the clinical cutoff (less than 25), the resulting effects were found to be clinically
equivalent to the benchmarks constructed from the FB conditions of the two PCOMS
group studies and the FB conditions from all six PCOMS studies. This should be
interpreted with some degree of caution as the benchmarks utilized for comparison to the
clinical cutoff sample were constructed from the complete samples of the RCTs (not just
those with a pretest score below cutoff, as such information was not available).
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There are several possible explanations for the elevated pretest score of the
present sample when compared to other PCOMS studies. Because participants in the
present study were referred to treatment and did not necessarily seek it voluntarily, it is
plausible that they did not perceive a problem or distress to exist. In other words, it is
possible that they would fall into the precontemplation stage of the transtheoretical model
of motivational readiness. This particular stage is characterized by a lack of awareness,
or an under-awareness, that a problem exists. As reviewed previously, clients falling into
the precontemplation stage of the transtheoretical model of motivational readiness to
change are most likely to be clients who entered into therapy because of some external
pressure (i.e., force from others); in this case, the criminal justice system (Prochaska et
al., 1992). Snyder and Anderson (2009) theorize a lack of motivation is potentially a
normal and expected reaction for precontemplators forced into treatment who experience
a double bind when acknowledging a problem exists. This provides one possible
explanation for the high mean intake score for the present sample. However, this is only
speculative as data regarding motivation and stages of change were not provided for the
present sample.
When considering the large mean ORS pretest score, it is also important to
consider the possibility that participants received mental health treatment while
incarcerated. According to a special report by the Bureau of Justice Statistics regarding
mental health treatment in state prisons (Beck & Maruschak, 2001), one in eight state
prisoners received some form of counseling services or mental health treatment at
midyear of 2000. Additionally, nearly 10% of state prisoners were prescribed
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psychotropic medication, including antidepressants, stimulants, sedatives, tranquilizers,
or other anti-psychotic drugs. As previously noted, Morgan, Winterowd, and Ferrell’s
(1999) national survey of group therapy in state correctional facilities reported an average
of 20% of male inmates of responding therapists received some type of group treatment
while incarcerated. It is possible that high pretest ORS were partially attributable to
previous psychotherapy services. Again, this is only speculative as no information was
made available regarding previous mental health treatment.
Another factor to consider when interpreting the results of the present study is the
potential double bind that exists for individuals referred to treatment when it comes to
acknowledging a problem. Clients referred to treatment may potentially experience a
desire to minimize distress for fear of how acknowledging a problem may impact their
standing with the referral source. For example, a client may fear repercussions from the
criminal justice system for admitting to struggles with substance use. Thus, it is possible
that the client minimizes and underreports problems in order to be viewed by the referral
source as doing well. Parolees in the present study may have been experiencing
psychological distress, but were hesitant to indicate such on the ORS for fear of how such
an admission would be interpreted or how it would potentially impact their standing on
parole. Participants may have experienced a fear that any indication of distress would
have been reported to the referral source and resulted in undesired consequences.
According to Mee-Lee, McLellan, and Miller (2010), it is common for mandated clients
to complete the measures in a manner that indicates little personal, interpersonal, and
social distress. Thus, it has been recommended that individuals mandated to treatment
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complete the outcome measure from the perspective of the referral source (Duncan et al.,
2004). However, this particular method of administration was not utilized with the
present sample. It is important to consider the notion that having the client complete the
outcome measures from the viewpoint of the referral source could potentially silence the
client’s own voice, which PCOMS aims to privilege during treatment.
Also of note, the treatment provided in the present study was found to be
clinically superior to the TAU conditions of all six PCOMS RCTs, which includes the
two group PCOMS studies. This finding suggests that the use of PCOMS with offenders
who have been referred to attend substance abuse treatment can lead to outcomes that are
superior to TAU. This finding is particularly noteworthy given that the data from the
present study was gathered from a naturalistic setting and represents “real-world”
treatment with offenders. The use of a continuous client feedback system privileges the
client’s voice and enables her or him to provide the clinician with information regarding
personal well-being and views of treatment progress. It is speculated that the use of a
client-directed, outcome informed therapy approach provides the referred client with a
sense of power and self-determination in an environment in which they otherwise may
experience coercion and a perceived loss of autonomy. The use of a continuous feedback
system may help to address the increased levels of resistance and decreased levels of
motivation and readiness to change that are characteristic of psychotherapy with coerced
clients.
Results of the supplemental analyses are also noteworthy. The rate of reliable
change for the present sample (37.77%) was descriptively larger than the rates observed
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in the two PCOMS group RCT studies (20.44% for Schuman et al., 2015 and 32.60% for
Slone et al., 2015). However, the rate of clinically significant change for the present
sample (11.60%) was descriptively smaller than those observed in the PCOMS group
RCTs (28.47% for Schuman et al., 2015 and 41.90% for Slone et al., 2015). Since the
mean pretest score for the present sample was well above the clinical cutoff, the
opportunity to obtain clinically significant change (which includes moving from below
the clinical cutoff to above it) was not available. The rate of deterioration for the present
sample was descriptively larger than that from the Slone et al. study (4.7%), but
descriptively smaller than that observed in the Schuman et al. study (14.60%).
Individuals from the Substance Use Recovery Program who successfully
completed treatment (i.e., attended at least six consecutive sessions and obtained two
consecutive negative drug tests) obtained outcomes that were clinically equivalent to
those observed in the FB conditions of the group PCOMS RCTs. Results were not found
to be clinically equivalent to those observed in the FB conditions of all PCOMS RCTs. It
is important to acknowledge that the two studies utilized to construct the benchmarks
were based on ITT samples, not completer samples. Information needed to construct
benchmarks on completer samples for Schuman et al. (2015) and Slone et al. (2015) was
not available. As such, caution should be utilized when interpreting and generalizing the
results. This concern can be tempered somewhat by noting the similarity in the number
of sessions attended by those in the completer sample from the present study (M = 7.06)
and the average number of sessions attended by participants in the FB conditions of the
two PCOMS group studies (M = 7.28).
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In regards to substance use, the rate of success from the present study was
descriptively lower than that observed in the treatment groups of a meta-analysis
examining the effectiveness of substance abuse treatment (Prendergast, Podus, Chang, &
Urada, 2002). However, it was descriptively larger than that observed in the comparison
group from the aforementioned meta-analysis. This finding suggests group substance
abuse treatment that utilizes continuous client feedback can result in substance abuse
outcomes superior to control groups. Results of the supplemental analyses are notable
given the characteristics that can impact therapeutic work with such a population. As
clients who experience coercion to attend therapy generally have lower levels of
motivation for treatment and higher levels of resistance than those who voluntarily seek
treatment, the findings from the supplemental analyses regarding treatment completers,
substance use rates, and clinical significance are noteworthy.
Study Limitations
Several limitations are noteworthy and need consideration when interpreting the
results of the present study. First, the use of a single, brief outcome measure (i.e., the
ORS) to assess pre-post change limits conclusions. Although four psychometric studies
have provided empirical evidence for the reliability and validity of scores generated by
the ORS, it does not provide the amount of information that a longer outcome measure
would (e.g., the OQ-45). However, the brief nature of the ORS makes it more feasible
for routine use in clinical settings.
Treatment fidelity also poses a limitation to the current study. Attempts were
made to address this via the implementation of PCOMS trainings, follow-up webinars,
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and supervision and feedback on the use of the measures. However, this direct feedback
regarding the implementation of the outcome system occurred only quarterly to annually
for clinicians. As such, it is possible that the outcome management system was not
utilized as intended. A potential sporadic use and discussion of the measures, as opposed
to during every session, may have led to a weakening of the intervention. No information
was available regarding clinicians’ reports of treatment fidelity.
Relatedly, another limitation of the present study is the modified implementation
of the outcome measure (i.e., the ORS). While the measure is designed for each visual
analog line to be scored to the nearest millimeter, nearly all scores for the present study
were provided in whole numbers. Clinicians were instructed to round to the nearest
centimeter, which resulted in whole number scores. Treatment providers were instructed
by the PCOMS trainer to utilize this method to add to the feasibility and simplicity of
scoring and recording. As previously mentioned, a modified administration method was
used in the Miller, Duncan, Brown, Sorrell, & Chalk (2006) study in which PCOMS was
administered over the telephone. Results should be interpreted with some caution as
psychometrics regarding modified administrations have not been examined.
In regards to the benchmarking methodology, several limitations are of note.
While the outcome measures utilized were identical, and thus matched on reactivity and
specificity, the samples being compared were not identical. With the exception of the
sample from Schuman et al. (2015) that included individuals who were primarily referred
for substance abuse treatment, the samples from the studies utilized to construct the
benchmarks primarily sought treatment on a voluntary basis. As no studies examining
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the efficacy of PCOMS with offenders exist in the literature, a best effort of equivalence
was utilized.
Additionally, no RCT studies examining the effectiveness of cognitive-behavioral
therapy (CBT) based substance abuse treatment for offenders were found that used a
comparable outcome measure. RCTs that were examined for inclusion focused primarily
on drug use or diagnosis specific outcomes, as opposed to global assessments of wellbeing. Snyder and Anderson (2009) noted several methodological shortcomings within
the literature on mandated substance abuse, including differences in outcomes measure,
differences in comparison groups, and inconsistencies in what constitutes mandated
therapy, that hindered the comparison of RCTs with the present study. Other research
syntheses regarding both group substance abuse treatment and general group treatment
for offenders were examined for possible inclusion in construction of a benchmark.
However, comparable studies were not found due to a lack of RCT design, differences in
population and focus of the groups, and lack of use of similar outcome measures. Thus,
only feedback benchmarks were used for comparison in the present study.
Implications and Future Recommendations
The present study, which is the first to examine the use of PCOMS with a sample
of offenders, expands our understanding of the use of a continuous client feedback
system with individuals referred to treatment. Despite the documented success in
treatment outcomes regarding the use of continuous client feedback with voluntary
clients, results of the present study suggest differences in effectiveness with individuals
referred to treatment. Although ES estimates from the present sample were not found to

94

be equivalent to those observed in the FB conditions of RCTs utilizing PCOMS,
treatment provided was found to be clinically superior to the TAU ES estimate from all
six PCOMS studies, including two conducted with groups. This finding suggests the use
of a continuous client feedback system with such a sample can be effective, but requires
further understanding of the nuances regarding referred treatment with offenders.
Particular characteristics of offender populations, including decreased motivation for
treatment and increased resistance to change when compared to individuals who
voluntarily seek services, may have influenced the observed outcomes. Findings of the
present study provide evidence for the continued exploration of the effectiveness of
continuous client feedback with offenders referred to treatment.
One noteworthy finding from the current study is the high mean pretest score
from the present sample, particularly when compared to the mean intake scores from the
six PCOMS RCTs. This appears to support previous reports that clients referred to
treatment will complete the measures in a manner that indicates low levels of distress
(Mee-Lee et al., 2010). Findings suggest that the use of client feedback with such a
population poses certain concerns that could benefit from being addressed in future
research. For example, future studies could examine the implementation of the feedback
system when offenders are asked to complete the measures from the viewpoint of the
referral source.
As was previously mentioned, no current RCT study exists to examine the
efficacy of a client feedback system with offenders who have been referred to treatment.
Based on the unique characteristics of such a sample, and the findings from the present
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study, such an examination appears warranted. Implementing measures of client
readiness to change, as well as an assessment of perceived coercion to treatment, would
also help to add to the understanding of treatment outcomes with this particular
population. Relationships between perceived coercion, motivation for treatment, client
resistance, and treatment outcomes could be examined in order to better understand the
impact of continuous client feedback on known characteristics of psychotherapy with
coerced clients.
Additionally, given the findings of the present study, it is recommended research
continue to examine the effects of continuous client feedback utilizing benchmarking
methodology. As benchmarking allows for a comparison of the effectiveness of realworld, naturalistic treatments with gold standards of care observed in rigorous RCTs, it is
recommended that the present study be replicated with other referred samples. The
present study provides methodological guidance for the continued evaluation of the
effectiveness of psychotherapy in real-world settings. As the present sample was
composed primarily of males, research examining the effects of client feedback with
female offenders referred to treatment would help to increase understanding of the unique
characteristics of such a population. Research could also examine the effectiveness of
continuous client feedback systems with juvenile offenders and offenders referred to
therapy for specific concerns (e.g., sex offender treatment, anger management, domestic
violence, etc.). As the present study focused on group treatment, it would also be
informative for future research to examine the use of continuous client feedback with
offenders in individual settings.
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Conclusions
The present study helps to expand our understanding of the effectiveness of
continuous client feedback, particularly with individuals who have been referred to
treatment. Though results were not found to be clinically equivalent to those observed in
the FB conditions from RCTs, they were found to be clinically superior to treatment as
usual for all PCOMS studies. Several known characteristics of coerced psychotherapy,
including client resistance and motivation for treatment, may have impacted the observed
treatment outcomes from the current study. Results indicate a difference in effectiveness
for the use of continuous client feedback with individuals referred to treatment, as
opposed to those who voluntarily seek services. Further research is needed to better
understand the use of a feedback system with such a sample. However, findings from the
present study suggest that it may be beneficial in producing outcomes superior to
treatment as usual.
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Appendix A
Outcome Rating Scale (ORS)

Outcome Rating Scale (ORS)

Name ________________________Age (Yrs):____
ID# _________________________ Sex: M / F
Session # ____ Date: ________________________
Looking back over the last week, including today, help us understand how you have been
doing in the following areas of your life, where marks to the left represent low levels and
marks to the right indicate high levels.

Individually:

(Personal well-being)
I----------------------------------------------------------------------I

Interpersonally:

(Family, close relationships)
I----------------------------------------------------------------------I

Socially:

(Work, School, Friendships)
I----------------------------------------------------------------------I

Overall:
(General sense of well-being)
I----------------------------------------------------------------------I

Institute for the Study of Therapeutic Change
_______________________________________
www.talkingcure.com
© 2000, Scott D. Miller and Barry L. Duncan
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Appendix B
PCOMS Graph

99

References
American Psychological Association Presidential Task Force on Evidence-Based
Practice (2006). Evidence based practice in psychology. American Psychologist,
61, 271- 285. doi: 10.1037/0003-066X.61.4.271
Anglin, M. D., Brecht, M. L., & Maddahian, E. (1989). Pre-treatment characteristics and
treatment performance of legally coerced versus voluntary methadone
maintenance admissions. Criminology, 27, 537–557. doi: 10.1111/j.17459125.1989.tb01045.x
Anglin, M. D., Prendergast, M., & Farabee, D. (1998). The effectiveness of coerced
treatment for drug abusing offenders. Federal Probation, 6(1), 3-10.
Anker, M. G., Duncan, B. L., & Sparks, J. A. (2009). Using client feedback to improve
couple therapy outcomes: A randomized clinical trial in a naturalistic setting.
Journal of Consulting and Clinical Psychology, 77, 693-705. doi:
10.1037/a0016062
Bachelor, A. (1991). Comparison and relationship to outcome of diverse dimensions of
the helping alliance as seen by client and therapist. Psychotherapy, 28, 534-549.
doi: 10.1037/0033-3204.28.4.534
Barlow, S. H., Burlingame, G. M., & Fuhriman, A. (2000). Therapeutic applications of
groups: From Pratt's 'thought control classes' to modern group psychotherapy.
Group Dynamics: Theory, Research, And Practice, 4, 115-134. doi:
10.1037/1089-2699.4.1.115

100

Beck, A. J., & Maruschak, L. M. (2001). Mental health treatment in state prisons, 2000
(NCJ No. 188215). U.S. Department of Justice, Bureau of Justice Statistics.
Retrieved from http://www.bjs.gov/
Becker, B. J. (1988). Synthesizing standardized mean-change measures. British Journal
of Mathematical and Statistical Psychology 41, 257–278. doi: 10.1111/j.20448317.1988.tb00901.x
Beutler, L. E., Harwood, T. M., Michelson, A., Song, X., & Holman, J. (2011).
Resistance/reactance level. Journal of Clinical Psychology: In Session, 67, 133142. doi: 10.1002/jclp.20753
Blume, S. B. (1985). Group psychotherapy in the treatment of alcoholism. In S. Zimberg,
J. Wallace, & S. B. Blume (Eds.), Practical Approaches to Alcoholism
Psychotherapy (pp. 7–107). New York, NY: Plenum Press.
Bordin, E. S. (1979). The generalizability of the psychoanalytic concept of the working
alliance. Psychotherapy, 16, 252-250. doi: 10.1037/h0085885
Brecht, M., & Anglin, M.D. (1993). Treatment effectiveness for legally coerced versus
voluntary methadone maintenance clients. American Journal of Drug and Alcohol
Abuse, 19 (1), 89-106.
Brecht, M., Anglin, M., & Dylan, M. (2005). Coerced treatment for methamphetamine
abuse: Differential patient characteristics and outcomes. The American Journal of
Drug and Alcohol Abuse, 31, 337-356. doi: 10.1081/ADA-200056764
Brehm, S., & Brehm, J. (1981). Psychological reactance: A theory of freedom and
control. New York, NY: Academic Press.

101

Breslin, F., Sobell, L. C., Buchan, G., & Cunningham, J. (1997). Toward a stepped-care
approach to treating problem drinkers: The predictive validity of within treatment
variables and therapist prognostic ratings. Addiction, 92, 1479-1489. doi:
10.1111/j.1360-0443.1997.tb02869.x
Bringhurst, D. L., Watson, C. W., Miller, S. D., & Duncan, B. L. (2006). The reliability
and validity of the Outcome Rating Scale: A replication study of a brief clinical
measure. Journal of Brief Therapy, 5(1), 23-30. Retrieved from
http://journalbrieftherapy.com/
Brogan, M. M., Prochaska, J. O., & Prochaska, J. M. (1999). Predicting termination and
continuation status in psychotherapy using the transtheoretical model.
Psychotherapy, 36, 105-113. doi: 10.1037/h0087773
Broome, K. M., Knight, D. K., Knight, K., Hiller, M. L., & Simpson, D. D. (1997). Peer,
family, and motivational influences on drug treatment process and recidivism for
probationers. Journal of Clinical Psychology, 53, 387-397. doi:
10.1002/(SIC)1097-4679(199706)53:4<387::AID-JCLP12>3.0.CO:2-C
Burke, A., & Gregoire, T. (2007). Substance abuse treatment outcomes for coerced and
noncoerced clients. Health and Social Work, 32(1), 7-15. doi: 10.1093/hsw/32.1.7
Burke, B. L., Arkowitz, H., & Menchola, M. (2003). The efficacy of motivational
interviewing: A meta-analysis of controlled clinical trials. Journal of Consulting
and Clinical Psychology, 71, 843-861. doi: 10.1037/0022-006X.71.5.843

102

Campbell, A., & Hemsley, S. (2009). Outcome Rating Scale and Session Rating Scale in
psychological practice: Clinical utility of ultra-brief measures. Clinical
Psychologist, 13, 1-9. doi: 10.1080/13284200802676391
Castonguay, L. G., Barkham, M. Lutz, W., & McAleavey, A. A. (2013). Practiceoriented research: Approaches and application. In M. J. Lambert (Ed.) Bergin and
Garfield’s handbook of psychotherapy and behavior change (6th ed., pp. 85-133).
New York, NY: Wiley.
Chapman, C. L., Burlingame, G. M., Gleave, R. M., Rees, F., Beecher, M., & Porter, G.
S. (2012). Clinical prediction in group psychotherapy. Psychotherapy Research,
22, 673–681.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd edition).
Hillsdale, NJ: Erlbaum.
Collins, J.J., & Allison, M.A. (1983). Legal coercion and retention in drug abuse
treatment. Hospital and Community Psychiatry, 34, 1145-1149.
Connors, G. J., DiClemente, C. C., Dermen, K. H., Kadden, R., Carroll, K. M., & Frone,
M. R. (2000). Predicting the therapeutic alliance in alcoholism treatment. Journal
of Studies on Alcohol, 61, 139-149.
Crits-Christoph, P., Ring-Kurtz, S., Hamilton, J. L., Lambert, M. J., Gallop, R., McClure,
B., . . . Rotrosen, J. (2012). A preliminary study of the effects of individual
patient-level feedback in out- patient substance abuse treatment programs.
Journal of Substance Abuse Treatment, 42, 301–309. doi:
10.1016/j.jsat.2011.09.003

103

Curtis, N. M., Ronan, K. R., Heiblum, N., & Crellin, K. (2009). Dissemination and
effectiveness of multisystemic treatment in New Zealand: A benchmarking
study. Journal of Family Psychology, 23, 119-129. doi: 10.1037/a0014974
Davies, D. R., Burlingame, G. M., Johnson, J. E., Gleave, R. L., & Barlow, S. H. (2008).
The effects of a feedback intervention on group process and outcome. Group
Dynamics: Theory, Research, and Practice, 12, 141-154. doi: 10.1037/10892699.12.2.141
De Leon, G., Melnick, G., Thomas, G., Kressel, D., & Wexler, H. K. (2000). Motivation
for treatment in a prison-based therapeutic community. American Journal of Drug
and Alcohol Abuse, 26(1), 33-46. doi: 10.1081/ADA-100100589
DiClemente, C. C., & Hughes, S. L. (1990). Stages of change profiles in alcoholism
treatment. Journal of Substance Abuse, 2, 217-235. doi: 10.1016/S08993289(05)80057-4
DiClemente, C. C., Schlundt, D., & Gemmell, L. (2004). Readiness and stages of change
in addiction treatment. The American Journal on Addictions, 13, 103-119. doi:
10.1080/10550490490435777
Dies, R. R., & Dies, K. R. (1993). The role of evaluation in clinical practice: Overview
and group treatment illustration. International Journal of Group Psychotherapy,
43, 77-105. Retrieved from http://www.guilford.com/
Drieschner, K. H., Lammers, S. M. M., & van der Staak, C. P. F. (2004). Treatment
motivation: An attempt for clarification of an ambiguous concept. Clinical
Psychology Review, 23, 1115-1137. doi: 10.1016/j.cpr.2003.09.003

104

Duncan, B. L. (2011). The Partners for Change Outcome Management System
(PCOMS): Administration, scoring, interpreting update for the Outcome and
Session Ratings Scale. Jensen Beach, FL: Author.
Duncan, B. L. (2012). The partners for change outcome management system (PCOMS):
The heart and soul of change project. Canadian Psychology, 53, 93-104.
Duncan, B. L. (2014). On becoming a better therapist: Evidence-based practice once
client at a time (2nd ed.). Washington, DC: American Psychological Association.
Duncan, B. L., & Miller, S. M. (2007). The group session rating scale. Chicago, IL:
Authors.
Duncan, B. L., Miller, S. D., & Sparks, J. A. (2004). The heroic client. San Francisco,
CA: Jossey-Bass.
Duncan, B. L., Miller, S. D., Wampold, B. E., & Hubble, M. A. (2010). The heart and
soul of change: Delivering what works in therapy (2nd ed.). Washington, DC:
American Psychological Association.
Duncan, B. L., & Reese, R. J. (2015). The Partners for Change Outcome Management
System (PCOMS): Revisiting the client’s frame of reference. Psychotherapy, 52,
391-401. http://dx.doi.org/10.1037/pst0000026
Duncan, B. L., & Sparks, J. (2010). Heroic clients, heroic agencies: Partners for change
(2nd ed.). Jensen Beach, FL: Authors.
Duncan, B. L., Sparks, J. Miller, S., Bohanske, R., & Claud, D. (2006). Giving youth a
voice: A preliminary study of the reliability and validity of a brief outcome
measure for children, adolescents, and caretakers. Journal of Brief Therapy, 5, 71-

105

87.
Duncan, E., Nicol, M., Ager, A., & Dalgleish, L. (2006). A systematic review of
structured group interventions with mentally disordered offenders. Criminal
Behavior and Mental Health, 16, 217-241. doi: 10.1002/cbm.631
Farabee, D., & Leukefeld, C. G. (2001). Recovery and the criminal justice system. In M.
T. Frank, C. G. Leukefeld, & J. J. Platt (Eds.), Relapse and recovery in addiction
(pp. 40-59). London, England: Yale University Press.
Fuhriman, A., Drescher, S., Hanson, E., & Henrie, R. (1986). Refining the measurement
of curativeness: An empirical approach. Small Group Behavior, 17, 186 –201.
Garvin, C. D. (1997). Contemporary group work (3rd ed.). Boston, MA: Allyn & Bacon.
Gillaspy, J. A., & Murphy, J. J. (2011). The use of ultra-brief client feedback tools in
SFBT. In C. W. Franklin, T. Trepper, E. McCollum, & W. Gingerich (Eds.),
Solution-focused brief therapy (pp. 73-94). doi:
10.1093/acprof:oso/9780195385724.003.0034
Glaze, L. E., & Kaeble, D. (2014). Correctional populations in the United States, 2013.
U.S. Department of Justice, Bureau of Justice Statistics. Retrieved from
http://www.bjs.gov/
Graham, K., Annis, H. M., Brett, P. J., & Venesoen, P. (1996). A controlled field trial of
group vs. individual cognitive-behavioural training for relapse prevention.
Addiction, 91, 1127–1139. doi: 10.1046/j.1360-0443.1996.91811275.x

106

Gurman, A. S. (1977). Therapist and patient factors influencing the patient’s perception
of facilitative conditions. Psychiatry: Journal of the Study of Interpersonal
Processes, 40, 218-231.
Hannan, C., Lambert, M. J., Harmon, C., Nielsen, S. L., Smart, D. W., & Shimokawa, K.
(2005). A lab test and algorithms for identifying clients at risk for treatment
failure. Journal of Clinical Psychology, 61, 155-163. doi: 10.1002/jclp.20108
Harford, R.J., Ungerer, J.C. & Kinsella, J.K. (1976). Effects of legal pressure on
prognosis for treatment of drug dependence. American Journal of Psychiatry,
133, 1399-1403.
Harmon, S. C., Lambert, M. J., Smart, D. M., Hawkins, E., Nielsen, S. L., Slade, K., &
Lutz, W. (2007). Enhancing outcome for potential treatment failures: Therapistclient feedback and clinical support tools. Psychotherapy Research, 17, 379– 392.
doi: 10.1080/1050330060 0702331
Hawkins, E. J., Lambert, M. J., Vermeersch, D. A., Slade, K. L., & Tuttle, K. C. (2004).
The thera- peutic effects of providing patient progress infor- mation to therapists
and patients. Psychotherapy Research, 14, 308–327. doi: 10.1093/ptr/kph027
Hedges, L. V. & Olkin, I. (1985). Statistical Methods for Meta-Analysis. San Diego, CA:
Academic Press.
Hiller, M L., Knight, K., Leukefeld, C., & Simpson, D. D. (2002). Motivation as a
predictor of therapeutic engagement in mandated residential substance abuse
treatment. Criminal Justice and Behavior, 29(1), 56-75. doi:
10.1177/0093854802029001004

107

Hiller, M L., Narevic, E., Webster, J. M., Rosen, P., Staton, M., Leukefeld, C., … Kayo,
R. (2009). Problem severity and motivation for treatment in incarcerated
substance abusers. Substance Use & Misuse, 44(1), 28-41. doi:
10.1080/10826080802523301
Horvath, A. O., & Symonds, B. D. (1991). Relation between working alliance and
outcome in psychotherapy: A meta-analysis. Journal of Counseling Psychology,
38, 139-149. doi: 10.1037/0022-0167.38.2.139
Howard, D. L., & McCaughrin, W. C. (1996). The treatment effectiveness of outpatient
substance misuse organizations between court mandated and voluntary clients.
Substance Use and Misuse, 31, 895-926. doi: 10.3109/10826089609063962
Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to
defining meaningful change in psychotherapy research. Journal of Consulting and
Clinical Psychology, 59(1), 12-19. doi: 10.1037/0022-006X.59.1.12
Joe, G. W., Simpson, D., & Broome, K. M. (1998). Effects of readiness for drug abuse
treatment on client retention and assessment of process. Addiction, 93, 1177-1190.
Karberg, J. C., & James, D. J. (2005). Substance dependence, abuse, and treatment of jail
inmates, 2002 (NCJ No. 209588). U.S. Department of Justice, Bureau of Justice
Statistics. Retrieved from http://www.bjs.gov/
Kelly, J. F., Finney, J. W., & Moos, R. (2005). Substance use disorder patients who are
mandated to treatment: Characteristics, treatment process, and 1- and 5-year
outcomes. Journal of Substance Abuse Treatment, 28, 213-223. doi:
10.1016/j.jsat.2004.10.014

108

Klag, S., O’Callaghan, F., & Creed, P. (2005). The use of legal coercion in the treatment
of substance abusers: An overview and critical analysis of thirty years of research.
Substance Use and Misuse, 40, 1777-1795. doi: 10.1080/10826080500260891
Lambert, M. (1992). Implications for outcome research for psychotherapy integration.
In J. C. Norcross & M. R. Goldstein (Eds.), Handbook of psychotherapy integration
(pp. 94-129). New York, NY: Basic Books.
Lambert, M. J. (2001). Psychotherapy outcome and quality improvement: Introduction to
the special section on patient-focused research. Journal of Consulting and
Clinical Psychology, 69, 147–149. doi: 10.1037/0022-006X.69.2.147
Lambert, M. J. (2010). Yes, it is time for clinicians to monitor treatment outcome. In B.
L. Duncan, S. C. Miller, B. E. Wampold, & M. A. Hubble (Eds.), The heart and
soul of change: Delivering what works in therapy (2nd ed., pp. 239–266).
Washington, DC: American Psychological Association.
Lambert, M. J. (2013). The efficacy and effectiveness of psychotherapy. In M. J. Lambert
(Ed.). Bergin and Garfield’s handbook of psychotherapy and behavior change (6th
ed., pp. 169-218). New York, NY: Wiley.
Lambert, M. J. (2015). Progress feedback and the OQ-System; The past and the future.
Psychotherapy, 52, 381-390. doi: 10.1037/pst0000027
Lambert, M. J., Hansen, N. B., Umphress, V., Lunnen, K. Okiishi, J., Burlingame, G. M.,
& Reisenger, C. W (1996). Administration and scoring manual for the OQ 45.2.
Stevenson, MD: American Professional Credentialing Services.

109

Lambert, M. J., Hatch, D. R., Kingston, M. D., & Edwards, B. C. (1986). Zung, Beck,
and Hamilton Rating Scales as measures of treatment outcome: a meta-analytic
comparison. Journal of Consulting and Clinical Psychology, 54(1), 54-59. doi:
10.1037//0022-006X.54.1.54
Lambert M. J., Kahler M., Harmon C., Burlingame G. M., Shimokawa K., White M. M.
(2013). Administration and Scoring Manual: Outcome Questionnaire OQ-45.2.
Salt Lake City, UT: OQ Measures.
Lambert, M. J., & Ogles, B. (2004). The efficacy and effectiveness of psychotherapy. In
M. J. Lambert (Ed.), Bergin and Garfield’s handbook of psychotherapy and
behavior change (5th ed., pp. 139-193). Hoboken, NJ: Wiley.
Lambert, M. J., & Shimokawa, K. (2011). Collecting client feedback. Psychotherapy,
48(1), 72-79. doi: 10.1037/a0022238
Lambert, M. J., Whipple, J. L., Smart, D. W., Vermeersch, D. A., Nielsen, S. L., &
Hawkins, E. J. (2001). The effects of providing therapists with feedback on
patient progress during psychotherapy: Are outcomes enhanced? Psychotherapy
Research, 11(1), 49-68. doi: 10.1080/713663852
Lambert, M. J., Whipple, J. L., Vermeersch, D. A., Smart, D. W., Hawkins, E. J.,
Nielson, S. L., & Goates, M. (2002). Enhancing psychotherapy outcomes via
providing feedback on client progress: A replication. Clinical Psychology and
Psychotherapy, 9(2), 91-103. doi: 10.1002/cpp.324
Larke, J. (1985). Compulsory treatment: Some practical methods of treating the mandated
client. Psychotherapy, 22, 262-268. doi: 10.1037/h0085504

110

Lee, C. M., Horvath, C., & Hunsley, J. (2013). Does it work in the real world? The
effectiveness of treatments for psychological problems in children and
adolescents. Professional Psychology: Research and Practice, 44, 81-88. doi:
10.1037/a0031133
Leukefeld, C., Gullotta, T. P., & Gregrich, J. (Eds.). (2011). Handbook of evidence-based
substance abuse treatment in criminal justice settings. New York, NY: Springer.
MacKenzie, K. R. (1981). Measurement of group climate. Journal of Group
Psychotherapy, 31, 287–296.
Magill, M., & Ray, L. (2009). Cognitive-Behavioral treatment with adult alcohol and
illicit drug users: A meta-analysis of randomized controlled trials. Journal of
Studies on Alcohol and Drugs, 70, 516-527.
Martin, D. J., Garske, J. P., & Davis, M. K. (2000). Relation of the therapeutic alliance
with outcome and other variables: A meta-analytic review. Journal of Consulting
and Clinical Psychology, 68, 438-450. doi: 10.1037/0022-006X.68.3.438
Marques, A. C., & Formigoni, M. L. (2001). Comparison of individual and group
cognitive-behavioral therapy for alcohol and/or drug-dependent patients.
Addiction, 96, 836–846. doi: 10.1046/j.1360-0443.2001.9668355.x
McConnaughy, E. A., Prochaska, J. O., & Velicer, W.F. (1983). Stages of change in
psychotherapy: Measurement and sample profiles. Psychotherapy: Theory,
Research and Practice, 20, 368–375.
McLellan, A.T., & Druley, K.A. (1977). A comparative study of response to treatment in
court- referred and voluntary drug patients. Hospital and Community Psychiatry,

111

28, 241-242.
Mee-Lee, D., McLellan, A. T., & Miller, S. D. What works in substance abuse and
dependence treatment. In B. L. Duncan, S. D. Miller, B. E. Wampold, & M. A.
Hubble (Eds.), The heart & soul of change: Delivering what works in therapy (2nd
ed., pp. 393-417). Washington, DC: American Psychological Association.
Merrill, K. A., Tolbert, V. E., & Wade, W. A. (2003). Effectiveness of cognitive therapy
for depression in a community mental health center: A benchmarking study.
Journal of Consulting and Clinical Psychology, 71, 404-409. doi: 10.1037/0022006X.71.2.404
Miller, S. D., & Duncan, B. L. (2000). The Outcome Rating Scale. Jensen Beach, FL:
Authors.
Miller, S. D., & Duncan, B. L. (2004). The outcome and session rating scales:
Administration and scoring manual. Ft. Lauderdale, FL: Authors.
Miller, S. D., Duncan, B. L., Brown, J., Sorrell, R., & Chalk, B. (2006). Using formal
client feedback to improve retention and outcome: Making ongoing, real-time
assessment feasible. Journal of Brief Therapy, 5(1), 5–22. Retrieved from
http://journalbrieftherapy.com/
Miller, S. D., Duncan, B. L., Brown, K., Sparks, J., & Claud, D. (2003). The outcome
rating scale: A preliminary study of the reliability, validity, and feasibility of a
brief visual analog measure. Journal of Brief Therapy, 2, 91-100. Retrieved from
http://journalbrieftherapy.com/
Miller, S. D., Duncan, B. L., & Johnson, L. (2002). The Session Rating Scale. Jensen

112

Beach, FL: Authors.
Miller, S. D., Mee-Lee, D., Plum, B., & Hubble, M. A. (2005). Making treatment count:
Client-directed, outcome-informed clinical work with problem drinkers. (2005).
Psychotherapy in Australia, 11, 42-56.
Miller, W. R., & Rollnick, S. (2002). Motivational Interviewing (2nd ed.). New York, NY:
Guilford Press.
Minami, T., Davies, D. R., Tierney, S. C., Bettmann, J. E., McAward, S. M., Averill, L.
A., …Wampold, B. E. (2009). Preliminary evidence on the effectiveness of
psychological treatments delivered at a university counseling center. Journal of
Counseling Psychology, 56, 309-320. doi: 10.1037/a0015398
Minami, T., Serlin, R. C., Wampold, B. E., Kircher, J. C., & Brown, G. S. (2008). Using
clinical trials to benchmark effects produced in clinical practice. Quality &
Quantity, 42, 513–525. doi: 10.1007/s11135-006-9057-z
Minami, T., Wampold, B. E., Serlin, R. C., Hamilton, E. G., Brown, G. S., & Kircher, J.
C. (2008). Benchmarking the effectiveness of psychotherapy treatment for adult
depression in a managed care environment: A preliminary study. Journal of
Consulting and Clinical Psychology, 76, 116-124. doi: 10.1037/0022006X.76.1.116
Minami, T., Wampold, B. E., Serlin, R. C., Kircher, J. C., & Brown, G. S. (2007).
Benchmarks for psychotherapy efficacy in adult major depression. Journal of
Consulting and Clinical Psychology, 75, 232-243. doi: 10.1037/0022006X.75.2.232

113

Mitchell, O., Wilson, D. B., & MacKenzie, D. L. (2007). Does incarcerated-based drug
treatment reduce recidivism? A meta-analytic synthesis of the research. Journal of
Experimental Criminology, 3, 353-375. doi: 10.1007/s11292-007-9040-2
Morgan, R. D., & Flora, D. B. (2002). Group psychotherapy with incarcerated offenders:
A research synthesis. Group Dynamics: Theory, Research, and Practice, 6, 203218. doi: 10.1037//1089-2699.6.3.203
Morgan, R. D., Winterowd, C. L., & Ferrell, S. W. (1999). A national survey of group
psychotherapy services in correctional facilities. Professional Psychology:
Research and Practice, 30, 600-606. doi: 10.1037/0735-7028.30.6.600
Moyers, T. B., & Rollnick, S. (2002). A motivational interviewing perspective on
resistance in psychotherapy. Journal of Clinical Psychology/In Session:
Psychotherapy in Practice, 58, 185-193.
Mumola, C. J., & Bonczar, T. P. (1995). Substance abuse and treatment of adults on
probation (NCJ No. 164267). U.S. Department of Justice, Bureau of Justice
Statistics. Retrieved from http://www.bjs.gov/
Mumola, C. J., & Karberg, J. C. (2006). Drug use and dependence, state and federal
prisoners, 2004 (NCJ No. 213530). U.S. Department of Justice, Bureau of Justice
Statistics. Retrieved from http://www.bjs.gov/
Norcross, J. C. (2010). The therapeutic relationship. In B. L. Duncan, S. D. Miller, B. E.
Wampold, & M. A. Hubble (Eds.), The heart and soul of change: Delivering what
works in therapy (2nd ed., pp. 113-142). Washington, DC: American
Psychological Association.

114

Norcross, J. C., Krebs, P. M., & Prochaska, J. O. (2011). Stages of change. Journal of
Clinical Psychology: In Session, 67, 143-154. doi: 10.1002/jclp.20758
Overholser, J. C. (2005). Contemporary psychotherapy: Promoting personal
responsibility for therapeutic change. Journal of Contemporary Psychotherapy,
35, 369-376. doi: 10.1007/s10879-005-6699-4
Polaschek, D. L. L., Anstiss, B., & Wilson, M. (2010). The assessment of offendingrelated stage of change in offenders: Psychometric validation of the URICA with
male prisoners. Psychology, Crime & Law, 16, 305-325. doi:
10.1080/10683160802698766
Prendergast, M. L., Podus, D., Chang, E., & Urada, D. (2002). The effectiveness of drug
abuse treatment: A meta-analysis of comparison group studies. Drug and Alcohol
Dependence, 67, 53-72.
Probst, T., Lambert, M. J., Loew, T. H., Dahlbender, R. W., Göllner, R., & Tritt, K.
(2013). Feedback on patient progress and clinical support tools for therapists:
Improved outcome for patients at risk of treatment failure in psychosomatic inpatient therapy under the conditions of routine practice. Journal of Psychosomatic
Research, 75, 255–261.
Prochaska, J. O., & DiClemente, C. C. (1982). Transtheoretical therapy: Toward a more
integrative model of change. Psychotherapy: Theory, Research and Practice, 20,
161-173.
Prochaska, J. O., & DiClemente, C. C. (1984). The transtheoretical approach: Crossing
traditional boundaries of change. Homewood, IL: Dorsey Press.

115

Prochaska, J. O., & DiClemente, C. C. (1986). Toward a comprehensive model of
change. In W. R. Miller & N. Heather (Eds.), Treating addictive behaviors:
Processes of change (pp. 3-27). New York, NY: Plenum.
Prochaska, J. O., & DiClemente, C. C. (1992). Stages of change in the modification of
problem behaviors. Progress in Behavior Modification, 28, 183-218.
Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992). In search of how people
change: Applications to addictive behaviors. American Psychologist, 47, 11021114.
Prochaska, J. O., Norcross, J. C., Fowler, J. L., Follick, M. J., & Abrams, D. B. (1992).
Attendance and outcome in a work site weight control program: Processes and
stages of change as process and predictor variables. Addictive Behaviors, 17, 3545. doi: 10.1037/0003-066X.47.9.1102
Prochaska, J. O., Velicer, W. F., DiClemente, C. C., & Fava, J. (1988). Measuring
processes of change: Application to the cessation of smoking. Journal of
Consulting and Clinical Psychology, 56, 520-528.
Reese, R. J., Duncan, B. L., Bohanske, R. T., Owen, J. J., & Minami, T. (2014).
Benchmarking outcomes in a public behavioral health setting: Feedback as a
quality improvement strategy. Journal of Consulting and Clinical Psychology, 82,
731-742.
Reese, R. J., Norsworthy, L. A., & Rowlands, S. (2009). Does a continuous feedback
system improve psychotherapy outcome? Psychotherapy: Theory, Research,
Practice, Training, 46, 418-431. doi: 10.1037/a0017901

116

Reese, R., Toland, M., Slone, N., & Norsworthy, L. (2010). Effect of client feedback on
couple psychotherapy outcomes. Psychotherapy, 47, 616-630. doi:
10.1037/a0021182
Robinson, I., & Davis-Kennington, P. (2002). Holding up half the sky: Women and
psychological resistance. Journal of Humanistic Counseling, Education and
Development, 41, 164-177.
Rollnick, S., Mason, P., & Butler, C. (1999). Health Behavior Change. London, England:
Churchill Livingstone.
Rooney, R. H. (Ed.). (2009). Strategies for work with involuntary clients, second edition.
New York, NY: Columbia University Press.
Rosenberg, C.M., & Liftik, J. (1976). Use of coercion in the outpatient treatment of
alcoholism. Journal of Studies on Alcohol, 37(1), 58-65.
Rosenthal, R., & Rubin, D. B. (1979). A note on percent variance explained as a measure
of the importance of effects. Journal of Applied Psychology, 9, 395-396.
Rosenthal, R., & Rubin, D. B. (1982). Comparing effect sizes of independent studies.
Psychological Bulletin, 92, 500-504.
Rotgers, F. (1992). Coercion in addiction treatment. In J. Langenbucher, B. S. McCrady,
W. Frankenstein, & P. E. Nathan (Eds.), Annual review of addictions research
and treatment (pp. 403-416). New York, NY: Pergamon.
Ryan, R. M., & Deci, E. L. (2008). A self-determination approach to psychotherapy: The
motivational basis for effective change. Canadian Psychology, 49, 186-193.

117

Ryan, R. M., Lynch, M. F., Vansteenkiste, M., & Deci, E. L. (2011). Motivation and
autonomy in counseling, psychotherapy, and behavior change: A look at theory
and practice. The Counseling Psychologist, 39, 193-260. doi:
10.1177/001000009359313
Salmon, R.W., & Salmon, R.J. (1983). The role of coercion in rehabilitation of drug
abusers. The International Journal of the Addictions, 18(1), 9-21.
Schmitz, J. M., Oswald, L. M., Jacks, S. D., Rustin, T., Rhoades, H. M., & Grabowski, J.
(1997). Relapse prevention treatment for cocaine dependence: Group vs.
individual format. Addictive Behaviors, 22, 405–418. doi: 10.1016/S03064603(96)00047-0
Schnoll, S.H., Goldstein, M.R., Antes, D.E., & Rinella, V.J. (1980). The impact of legal
involvement on substance abusers in a residential treatment setting. Corrective
and Social Psychology, 26(1), 21-28.
Schuman, D. L., Slone, N. C., Reese, R. J., & Duncan, B. (2015). Efficacy of client
feedback in group psychotherapy with soldiers referred for substance abuse
treatment. Psychotherapy Research, 25, 396-407. doi:
10.1080/10503307.2014.900875
Serlin, R. C., & Lapsley, D. K. (1985). Rationality in psychological research: The goodenough principle. American Psychologist, 40, 73-83. doi:1 0.1037/0003066X.40.1.73
Serlin, R. C., & Lapsley, D. K. (1993). Rational appraisal of psychological research and
the good-enough principle. In G. Keren & C. Lewis (Eds.), A handbook for data

118

analysis in the behavioral sciences: Methodological issues (pp. 199–228).
Hillsdale, NJ: Erlbaum.
Shapiro, D. A., & Shapiro, D. (1982). Meta-analysis of comparative therapy outcome
studies: A replication and refinement. Psychological Bulletin, 92, 581-604.
Shimokawa, K., Lambert, M. J., & Smart, D. W. (2010). Enhancing treatment outcome of
patients at risk of treatment failure: Meta-analytic and mega-analytic review of
psychotherapy quality assurance system. Journal of Consulting and Clinical
Psychology, 78, 298-311. doi: 10.1037/a0019247
Siddall, J.W., & Conway, G.L. (1988). Interactional variables associated with retention
and success in residential drug treatment. The International Journal of the
Addictions, 23, 1241-1254.
Simon, W., Lambert, M. J., Busath, G., Vazquez, A., Berkeljon, A., Hyer, K., . . . Berrett,
M. (2013). Effects of providing patient progress feedback and clinical support
tools to psychotherapists in an inpatient eating disorders treatment program: A
randomized controlled study. Psychotherapy Research, 23, 287–300.
http://dx.doi.org/10.1080/10503307.2013.787497
Simpson, D.D., & Friend, H.J. (1988). Legal status and long-term outcomes for addicts in
the DARP followup project. In C.G. Leukefeld and F.M. Tims (Eds.),
Compulsory treatment of drug abuse: Research and clinical practice. NIDA
Research Monograph 86, DHHS number (ADM)89-1578, pp. 81-98.
Slade, K., Lambert, M. J., Harmon, S. C., Smart, D. W., & Bailey, R. (2008). Improving
psychotherapy outcome: The use of immediate electronic feedback and revised

119

clinical support tools. Clinical Psychology & Psychotherapy, 15, 287–303.
Slone, N. C., Reese, R. J., Mathews-Duvall, S., & Kodet, J. (2015). Evaluating the
efficacy of client feedback in group psychotherapy. Group Dynamics: Theory,
Research, and Practice, 19, 122-136. doi: 10.1037/gdn0000026
Slonim-Nevo, V. (1996). Clinical practice: Treating the non-voluntary client.
International Social Work, 39, 117-129. doi: 10.1177/002087289603900202
Smith, M. L., Glass, G. V., & Miller, T. I. (1980). The benefits of psychotherapy.
Baltimore, MD: Johns Hopkins University Press.
Snyder, C. M., & Anderson, S. A. (2009). An examination of mandated versus voluntary
referral as a determinant of clinical outcome. Journal of Marital and Family
Therapy, 35, 278-292. doi: 10.1111/j.1752-0606.2009.00118.x
Sparks, J. A., Duncan, B. L., & Miller, S. D. (2008). Common factors in psychotherapy.
In J. L. Lebow (Ed.), Twenty-first century psychotherapies: Contemporary
approaches to theory and practice (pp. 453-497). Hoboken, NJ: John Wiley &
Sons, Inc.
Staton-Tindall, M., McNees, E., Leukefeld, C. G., Walker, R., Thompson, L., Pangburn,
K., & Oser, C. B. (2009). Systematic outcomes research for corrections-based
treatment: Implications from the criminal justice Kentucky treatment outcome
study. Journal of Offender Rehabilitation, 48, 710-724. doi:
10.1080/10509670903287824
Stiles, W. B., Barkham, M., Connell, J., & Mellor-Clark, J. (2008). Responsive regulation
of treatment duration in routine practice in United Kingdom primary care settings:

120

Replication in a large sample. Journal of Consulting and Clinical Psychology, 76,
298-305. doi: 10.1037/0022-006X.76.2.298
Storch, R. S., & Lane, R. C. (1989). Resistance in mandated psychotherapy: Its function
and management. Journal of Contemporary Psychotherapy, 19(1), 25-38.
Substance Abuse and Mental Health Services Administration (2012). National registry of
evidence-based programs and practices. Retrieved from http://nrepp.samhsa.gov
Taxman, F. S. (2011). Parole: “What works” is still under construction. In C. Leukefeld,
T. P. Gullotta, & J. Gregrich (Eds.), Handbook of evidence-based substance abuse
treatment in criminal justice settings (pp. 205-227). New York, NY: Springer.
Wade, W. A., Treat, T. A., & Stuart, G. L. (1998). Transporting an empirically supported
treatment for panic disorder to a service clinic setting: A benchmarking strategy.
Journal of Consulting and Clinical Psychology, 66, 231-239. doi: 10.1037/0022006X.66.2.231
Walfish, S., McAlister, B., O’Donnell, P., & Lambert, M. (2012). An investigation of
self-assessment bias in mental health providers. Psychotherapy Research, 110,
639-644.
Wampold, B. E. (2001). The great psychotherapy debate: Model, methods, and findings.
Mahwah, NJ: Lawrence Erlbaum.
Wampold, B. E., Mondin, G. W., Moody, M., Stich, F., Benson, K., & Ahn, H. (1997). A
meta-analysis of outcome studies comparing bona fide psychotherapies:
Empirically, ‘all must have prizes.’ Psychological Bulletin, 122, 203-215. doi:
10.1037/0033-2909.122.3.203

121

Weersing, V. R., & Weisz, J. R. (2002). Community clinic treatment of depressed youth:
Benchmarking usual care against CBT clinical trials. Journal of Consulting and
Clinical Psychology, 70, 299–310. doi: 10.1037/0022-006X.70.2.299
Weiss, R. D., Jaffee, W. B., de Menil, V. P., & Cogley, C. B. (2004). Group therapy for
substance use disorders: What do we know? Harvard Review of Psychiatry, 12,
339-350. doi: 10.1080/10673220490905723
Whipple, J. L., Lambert, M. J., Vermeersch, D. A., Smart, D. W., Nielsen, S. L., &
Hawkins, E. J. (2003). Improving the effects of psychotherapy: The use of early
identification of treatment failure and problem-solving strategies in routine
practice. Journal of Counseling Psychology, 50(1), 59-68. doi:10.1037/00220167.50.1.59
Yalom, I. D. (2005). The theory and practice of group psychotherapy (5th ed.). New
York, NY: Basic Books.
Yalom, I. D., & Lieberman, M. A. (1971). A study of encounter group casualties.
Archives of General Psychiatry, 25(1), 16-30.
Young, D. (2002). Impacts of perceived legal pressure on retention in drug treatment.
Criminal Justice and Behavior, 29(1), 27-55. doi:
10.1177/0093854802029001003

122

Curriculum Vitae
ALYSSA BAILEY GROSSL
EDUCATION:
2010-2011

Education Specialist in Counseling Psychology
University of Kentucky; Lexington, KY

2008-2010

Master of Science in Counseling Psychology
University of Kentucky; Lexington, KY

2004-2008

Bachelor of Arts in Psychology (Magna Cum Laude)
Georgetown College; Georgetown, KY

SUPERVISED CLINICAL AND SUPERVISION EXPERIENCE
Pre-Doctoral Internship:
Federal Medical Center, Lexington (July 2014-July 2015)
Site Supervisors: Adu Boateng, PhD, Training Director; Ashley Burgett, PhD; Megan
Schuster, PhD
Practicum/Group:
Federal Medical Center, Lexington (September 2013-July 2014)
Site Supervisors: Megan Schuster, PhD and Adu Boateng, PhD
Program Supervisors: Pam Remer, PhD, Danelle Stevens-Watkins, PhD, and Daniel
Walinsky, PhD
University of Kentucky Counseling Psychology Program (Summer 2013; Fall 2009)
Supervisor: Rory Remer, PhD
Georgetown College Counseling Center (August 2012-May 2013)
Site Supervisor: Lloyd Clark, PhD
Program Supervisor: Keisha Love, PhD
University of Kentucky Counseling Center (January 2011-May 2012)
Site Supervisors: Di Sobel, PhD; Tina Bryant, PhD; Aesha Tyler, PsyD; Susan
Matthews, PhD
Program Supervisor: Jeff Reese, PhD
Gatton Diversity Group Co-Leader (August 2010-December 2010)
Supervisors: Randa Remer, PhD and Pamela Remer, PhD
Family Counseling Service (September 2009-April 2010)
123

Site Supervisor: LaDonna K. Tyler, LCSW
Program Supervisor: Pam Remer, PhD and Janelle McNeal, PhD
Lexington Center for Women, Children, and Families (2007-2008)
Domestic Violence Counseling and Crisis Management
Supervisor: Sara Hicks, MSW, Licensed Marriage and Family Therapist
Program Supervisor: Regan Lookadoo, PhD
Supervision of Students:
Federal Medical Center, Lexington (February 2015-July 2015)
Supervisor: Megan Schuster, PsyD
University of Kentucky Counseling Psychology Program (Fall 2013)
Facilitator for Master’s Students Leading Therapy Group
Supervisor: Rory Remer, PhD
University of Kentucky Counseling Psychology Program (Spring 2014; Spring 2013;
Spring 2012)
Supervisor of Master’s Students
Supervisor: Jeff Reese, PhD
RESEARCH:
Publications (Peer-Reviewed):
Grossl, A. B., Reese, R. J., Norsworthy, L. A., & Hopkins, N. B. (2014). Client feedback
data in supervision: Effects on Supervision and Outcome. Training and Education
in Professional Psychology, 8, 182-188.
Zimmerman, R. S., Cupp, P. K., Abadi, M., Donohew, R. L., Gray, C., Gordon, L., &
Grossl, A. B. (2014). The effects of framing and fear on ratings and impact of
anti-marijuana PSAs. Substance Use & Misuse, 49, 824-835.
Conference Presentations:	
  
	
  
Cupp,	
  P.	
  K.,	
  Zimmerman,	
  R.	
  S.,	
  Harris,	
  M.,	
  Donohew,	
  R.	
  L.,	
  Gray,	
  C.,	
  &	
  Grossl,	
  A.	
  B.	
  
(November,	
  2011).	
  	
  Effects	
  of	
  framing	
  and	
  fear	
  on	
  impact	
  of	
  condom	
  PSAs.	
  
Poster	
  presentation	
  at	
  the	
  Mass	
  Media	
  Exposure	
  and	
  Health	
  Behaviors	
  
session	
  of	
  the	
  American	
  Public	
  Health	
  Association	
  Annual	
  Meeting,	
  
Washington,	
  D.C.	
  
	
  

124

Grossl,	
  A.	
  B.,	
  &	
  Reese,	
  R.	
  J.	
  (August,	
  2012).	
  The	
  influence	
  of	
  client	
  feedback	
  on	
  the	
  
supervisee	
  alliance	
  and	
  supervisee	
  satisfaction	
  in	
  clinical	
  supervision.	
  	
  Poster	
  
presentation	
  at	
  the	
  American	
  Psychological	
  Association	
  Annual	
  Convention,	
  
Orlando,	
  FL.	
  	
  
Reese, R. J., Banks, J. R., White, C. L., Sievers, H. M., Gifford, B. L., Grossl, A. B.,
...Roll, B. D. (2010, August). Client feedback in psychotherapy: Improving
outcomes and empowering clients? Poster presented at the annual meeting of the
American Psychological Association, San Diego, CA.
Slone,	
  N.	
  C.,	
  Grossl,	
  A.	
  B.,	
  Schulz,	
  B.,	
  Newsome,	
  B.,	
  Buschar,	
  C.,	
  Perkins,	
  A.,	
  Reese,	
  R.	
  J.,	
  
Prout,	
  T.	
  H.	
  (August,	
  2012).	
  Reliability	
  and	
  validity	
  of	
  TIPS:	
  A	
  brief	
  
psychotherapy	
  outcome	
  measure.	
  Poster	
  presentation	
  at	
  the	
  American	
  
Psychological	
  Association	
  Annual	
  Convention,	
  Orlando,	
  FL.	
  
	
  
Slone,	
  N.	
  C.,	
  Grossl,	
  A.	
  B.,	
  Schulz,	
  B.,	
  Newsome,	
  B.,	
  Buschar,	
  C.,	
  Perkins,	
  A.,	
  Reese,	
  R.	
  J.,	
  
Prout,	
  T.	
  H.	
  (October,	
  2010).	
  Reliability	
  and	
  validity	
  of	
  TIPS:	
  A	
  brief	
  
psychotherapy	
  outcome	
  measure. Presentation at the Southeastern Regional
Counseling Psychology Conference, Radford, VA. 	
  
Research Assistantship:
Center for Drug Abuse Research Translation, Project 4 (January 2009-July 2011)
Supervisors: Rick Zimmerman, PhD and Pam Cupp, PhD
Research in Progress:
Cupp, P., Zimmerman, R., Donohew, R. L., Harris, M., Grossl, A. B., & Gray, C.
Relationship of individual differences and level of threat and framing of messages
to ratings of condom PSAs and impact of PSAs on attitudes.
Slone, N. C., Reese, R. J., Prout, T. H., Grossl, A. B., Schultz, B., Newsome, B.,
Buschar, C., Perkins, A., Reliability and Validity of TIPS: A Brief Psychotherapy
Outcome Measure.
TEACHING EXPERIENCE:
Behavioral Sciences Department (Summer 2012; Summer 2013-Summer 2014)
University of Kentucky; Lexington, KY
Supervisors: John Wilson, PhD and Raven Piercey, PhD
Academic Enhancement at The Study (August 2011-May 2013)
University of Kentucky; Lexington, KY
Supervisor: Ali Cicerchi

125

AWARDS AND HONORS:
Recipient of Time Off Award at Federal Medical Center, Lexington
Recipient of Arvie and Ellen Turner Thacker Research Fund grant for dissertation.
Recipient of a travel award for poster (The Influence of Client Feedback on Supervisee
Alliance and Supervisee Satisfaction in Supervision) presented at the social hour
sponsored by CCPTP, SAG, and the sections of Division 17 at the APA convention in
Orlando, Florida, in August 2012. The travel award was on behalf of the Section on
Supervision and Training of Division 17.
PROFESSIONAL MEMBERSHIPS/GROUPS:
American Psychological Association Graduate Student Affiliate
American Psychological Association, Division 17 (Society for Counseling Psychology)
American Psychological Association, Division 35 (Society for the Psychology of Women)
American Psychological Association of Graduate Students
COMMITTEES/TRAININGS:
Student Advisory Committee for Program Accreditation Review (February 2011November 2011)
Served as a member of a student committee aimed at preparing for the American
Psychological Association’s program accreditation visit. Assisted Director of Training in
review of program goals and outcomes.
Ally Development Workshop (Leader) (August 2011, August 2012)
Helped plan and facilitate a six-hour diversity training workshop sponsored by the
Department of Counseling Psychology. Focus of the workshop was on increasing
awareness and appreciation of oppressed groups, as well as becoming an ally for said
groups.
Ally Development Workshop (Participant) (August 2010)
Attended a six-hour diversity training workshop sponsored by the Department of
Counseling Psychology during which focus was placed on increasing awareness and
appreciation of oppressed groups.

126

